chitosan has been researched along with Neoplasms in 418 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (0.48) | 18.2507 |
| 2000's | 27 (6.46) | 29.6817 |
| 2010's | 235 (56.22) | 24.3611 |
| 2020's | 154 (36.84) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Li, H; Liu, M; Lu, W; Svirskis, D; Wen, J; Ying, M | 1 |
| Ahn, CH; Jo, S; Kim, J; Kim, K; Lim, DK; Sun, IC; Yun, WS | 1 |
| Dao, TP; Doan, P; Doan, VD; Nguyen, BT; Nguyen, DT; Nguyen, VT; Plavskii, V; Tran, NQ | 1 |
| Chen, L; Chen, W; Cheng, H; Xia, W; Zhan, X | 1 |
| Al-Nemrawi, NK; Altawabeyeh, RM; Darweesh, RS | 1 |
| Huang, Y; Jiang, X; Liu, X; Ma, P; Mu, X; Song, D; Wang, W; Zhang, S; Zhang, Y | 1 |
| Chen, C; Chen, J; Ding, X; Li, C; Li, Z; Liu, J; Mei, E; Xi, Q; Zhou, S | 1 |
| Aboushoushah, SF; Elbialy, NS; Mohamed, N | 1 |
| Bidram, E; Bigham, A; Esmaeili, Y; Jolfaie, NA; Khavani, M; Rafienia, M; Sanati, A; Shariati, L; Zarrabi, A | 1 |
| Huang, QF; Li, YH; Liao, JX; Wang, GH; Zhang, DW | 1 |
| Abuelmakarem, HS; Ahmed, WA; El-Azab, J; Farghaly, M; Om-Hashem, MA; Sliem, MA | 1 |
| Li, Q; Lv, X; Tang, C; Yin, C | 1 |
| Alhakamy, NA; Kesharwani, P; Md, S; Sheikh, A | 1 |
| Chen, H; Kong, M; Li, H; Shi, Y; Yu, M; Zhang, W; Zhao, J | 1 |
| Chen, H; Feng, C; Gao, Y; Li, X; Wang, Y | 1 |
| Fan, R; Guo, G; Liang, X; Mu, M; Zou, B | 1 |
| Behzadmehr, R; Bilal, M; Mirinejad, S; Pandey, S; Qindeel, M; Rahdar, A; Sargazi, S; Siddiqui, B | 1 |
| Angelini, C; Argenziano, M; Cavalli, R; Giovarelli, M; Novelli, F; Occhipinti, S; Scomparin, A; Soster, M | 1 |
| Ge, Y; Liu, X; Liu, Y; Tang, R; Wang, D; Wang, Z; Wu, H; Yan, G | 1 |
| Hu, F; Shang, X; Yu, F; Yuan, H; Zhu, Y | 1 |
| Alhajamee, M; Homayouni Tabrizi, M; Khademi, D; Sadeghzadeh, F; Torshizi, GH; Ziaratnia, AS | 1 |
| Karimi, Z; Minaiyan, M; Mirian, M; Taymouri, S | 1 |
| Baharlouei, P; Rahman, A | 1 |
| Bidram, E; Esmaeili, Y; Ghasemi, F; Rafienia, M; Seyedhosseini Ghaheh, H; Shariati, L; Zarrabi, A | 1 |
| Boddu, A; Lai, WF; Obireddy, SR; Rao, KSVK; Zhang, D | 1 |
| Jeong, GJ; Khan, F; Khan, S; Kim, YM; Tabassum, N | 1 |
| Cai, T; Cao, Y; Chen, Y; He, X; Huang, J; Lin, Y; Wen, Z; Yu, C; Zhang, L | 1 |
| Abd-Allah, FI; Abu Elyazid, SK; El-Sawy, HS; El-Say, KM; Ismael, HR; Lila, AE; Megahed, MA; Reda, AM | 1 |
| Cao, D; Kuang, Y; Liu, X; Lu, J; Luo, Y; Wang, J; Wang, X; Xia, W; Yuan, C; Zhang, Z | 1 |
| Ajalli, N; Díez-Pascual, AM; Navaei-Nigjeh, M; Pourmadadi, M; Rashedi, H; Yazdian, F | 1 |
| Cai, N; Chen, D; Chen, Q; Guo, Y; Hou, X; Li, Y; Liu, C; Lu, Y; Qiu, Z; Shen, W; Sun, C; Tu, J; Zhou, M; Zhou, S | 1 |
| Alallam, B; Alfatama, M; Choukaife, H; Doolaanea, AA; Seyam, S | 1 |
| Ghasemi, MH; Khosravi, AR; Tousian, B | 1 |
| Bedhiafi, T; Billa, N; Dermime, S; Hijji, Y; Idoudi, S; Korashy, HM; Merhi, M; Uddin, S | 1 |
| Coutinho, AJ; Neves, AR; Pinheiro, M; Pinto, MMM | 1 |
| Krishna, NG; Sailaja, GS; Sumitha, NS | 1 |
| Liao, L; Liu, Z; Wang, P; Wei, J; Xiao, L; Yan, X; Zhou, D | 1 |
| Bai, Y; Li, J; Liu, X; Lu, M; Qiu, T; Yang, M; Yuan, M; Zhan, S; Zhang, X | 1 |
| Jiang, X; Liu, Y; Luo, W; Qi, X; Shen, J; Xiang, X; Zheng, C; Zhou, Z | 1 |
| Abdellatif, AAH; Algheshairy, RM; Alhomaid, RM; Aljutaily, T; Almujaydil, MS; Almutairi, AS; Alshimali, SI; Barakat, H | 1 |
| Alarifi, S; Ali, D; Aruni, W; Elangovan, N; Govarthanan, K; Kalirajan, A; Mani, P; Mani, R; Manimaran, D; Palanisamy, CP; Palanisamy, V; Rangasamy, K; Shanmugam, R; Srinivasan, GP; Subramanian, K; Zhang, H | 1 |
| Dong, W; Huang, X; Li, Q; Liang, X; Lu, Y; Xu, X; Zhao, G | 1 |
| El-Khayat, Z; Elshaarawy, RFM; Hafez, HS; Kotb, ES; Serag, WM | 1 |
| Al-Farraj, ES; Bakr, AF; El-Sherbiny, IM; Ghoniem, MG; Ibrahim, A; Khalil, IA; Mahmoud, MY | 1 |
| Chen, X; Cheng, Y; Gou, K; Li, H; Lv, J; Ma, Z; Xin, W; Yang, J; Zeng, R; Zhao, L | 1 |
| Abbas, N; Akram, MU; Farman, M; Khan, MI; Luque, R; Manzoor, S; Osman, SM; Shanableh, A | 1 |
| Khadiv-Parsi, P; Pourmadadi, M; Rashedi, H; Sabzini, M; Yazdian, F | 1 |
| Chen, Z; Hu, Y; Lei, M; Liu, A; Qin, Y; Wang, D; Wang, X; Wang, Z; Wen, T; Yang, L; Zhang, L; Zhang, T; Zhu, Y | 1 |
| Cai, HL; Lv, Z; Song, R; Song, X; Tang, W; Wang, Y; Wei, J; Wu, XS; Wu, Y; Yang, D; Zhang, A; Zhong, W; Zhou, X | 1 |
| Li, Z; Liang, N; Sun, S; Yan, P; Zhao, W | 1 |
| Ma, J; Song, Y; Yan, G; Zhang, C | 1 |
| Chiang, WH; Chin, HY; Hsu, TC; Huang, SY; Tzang, BS; Wang, TH; Yeh, NT | 1 |
| Biswasroy, P; Ghosh, G; Haldar, J; Kar, B; Pradhan, D; Rai, VK; Rajwar, TK; Rath, G; Rout, SR; Sarangi, MK | 1 |
| Chiang, WH; Chu, CY; Huang, HJ; Huang, NC; Huang, SY; Jeng, US; Lin, TY; Shih, O; Wang, TH | 1 |
| El-Mazaly, MH; Hanna, DH; Mohamed, RR | 1 |
| Ghadi, FE; Naeimi, A; Parizi, ZP; Rezakhani, MS | 1 |
| Chen, Q; Liu, X; Ma, G; Oku, H; Wu, J; Zou, Y | 1 |
| Chang, H; Jeon, S; Kim, K; Lee, S; Shim, MK; Yhee, JY; Yoon, HY | 1 |
| Fan, Y; Liu, Y; Lu, L; Peng, S; Rong, L; Su, Y; Xiao, J; Yuan, W; Zhan, M | 1 |
| Azzi, F; Cunningham, N; Lapointe, R; Lerouge, S; Malaret, T; St-Jean, G; Thébault, P; Trudel, D | 1 |
| Abdellatif, AAH; Al-Subaiyel, A; Mohammed, AM | 1 |
| Kumar, M; Rani, V; Verma, R | 1 |
| Aalhate, M; Gupta, U; Mahajan, S; Maji, I; Nair, R; Paul, P; Singh, PK | 1 |
| Ling, J; Ouyang, XK; Wang, N; Xu, X; Zhu, Y | 1 |
| Bhaskar, R; Dewanjee, S; Ghosh, S; Han, S; Jha, NK; Jha, SK; Kesari, KK; Negi, A; Paiva-Santos, AC; Sachdeva, B; Sachdeva, P; Sinha, JK | 1 |
| Cao, Y; Chen, C; Chen, J; Hu, M; Li, Y; Li, Z; Shan, P; Shao, J; Zheng, C; Zhou, S; Zhu, B | 1 |
| Barati Naeeni, N; Ghafaripour, H; Homayouni Tabrizi, M; Karimi, E | 1 |
| Li, J; Qin, J; Sun, M; Wang, D; Zhen, Y | 1 |
| Hua, S; Liu, J; Tian, B | 1 |
| Ambre, P; Coutinho, E; Gupta, C; Singh, P; Vaidya, S | 1 |
| Akkaya, B; Akkaya, R; Nazlim, A | 1 |
| Aruna, S; Gopal, M; Kesavan, S; Rajesh, D; Shanmugam, J; Vijayakumar, S | 1 |
| Iskandar, A; Wong, TW; Zaiki, Y | 1 |
| Arias, JL; Caro, C; Fernández-Álvarez, F; García-García, G; García-Martín, ML | 2 |
| Jiang, T; Meng, X; Wang, T; Yu, Y; Zhao, X | 1 |
| Luo, X | 1 |
| Carlton Ranjith, WA; Kundu, BK; Mukhopadhyay, S; Sarkar, S; Singh, S; Sonawane, A | 1 |
| Binbr Abe Menen, N; Rouhi, O; Yang, H; Zhang, Z; Zhou, X | 1 |
| da Fonseca Filho, HD; Ghegoiu, L; Liliana Iconaru, S; Matos, RS; Predoi, D; Steluţa Ciobanu, C; Ţălu, Ş | 1 |
| Chen, L; Chen, Q; Chen, Z; Fan, J; Guo, D; Lai, J; Li, Q; Liang, J; Lin, J; Wei, J; Zhang, B; Zhang, Y | 1 |
| De Wael, K; Detamornrat, U; Domínguez-Robles, J; Donnelly, RF; Parrilla, M; Tunca, S | 1 |
| Gaber, M; Ghareeb, D; Hamed, A; Hamed, M; Mohamed, TM; Nofal, MS | 1 |
| Qian, Z; Xu, S; Yuan, W; Zhao, N | 1 |
| Doan, VHM; Hoang, G; Jun, SW; Kim, CS; Kim, H; Kim, J; Manivasagan, P; Mondal, S; Nguyen, VT; Oh, J | 1 |
| Asgharnasl, S; Eivazzadeh-Keihan, R; Hajizadeh, Z; Maleki, A; Radinekiyan, F; Salimi Bani, M | 1 |
| Chen, GB; Chen, GH; Chen, H; Li, JZ; Lin, JT; Wang, D; Xiong, L | 1 |
| Asgharzadeh, M; Baradaran, B; Ghorbanihaghjo, A; Rashedi, J | 1 |
| Liu, P; Xie, P | 1 |
| Öztürk, AA; Şenel, B | 1 |
| Cheng, YM; Lai, YL; Yen, SK | 1 |
| Balan, P; Indrakumar, J; Korrapati, PS; Murali, P | 1 |
| Chen, D; Hu, H; Ji, H; Li, J; Zhao, M | 1 |
| Al-Dhubiab, BE; Alzahrani, AM; Maheshwari, R; Sharma, MC; SreeHarsha, N; Tekade, M; Tekade, RK; Venugopala, KN | 1 |
| Jun, SW; Kang, YH; Kim, CS; Kwon, J; Lee, J; Ly, CD; Manivasagan, P; Mondal, S; Nguyen, VT; Oh, J | 1 |
| Chu, K; Han, L; Li, T; Ouyang, H; Qiu, L; Wang, X; Xu, W; Zhang, X | 1 |
| Akkaya, B; Kocabay, S | 1 |
| El-Naggar, MM; Haneen, DSA; Khalil, MT; Mehany, ABM | 1 |
| Al-Duais, MA; Alalawy, AI; Almutairi, FM; El Rabey, HA; Sakran, MI; Tayel, AA; Zidan, NS | 1 |
| Jia, HR; Lin, F; Wu, FG | 1 |
| Cheng, L; Li, J; Liu, C; Liu, Y; Lu, H; Wang, D; Wei, J; Xu, B; Yin, S | 1 |
| Hu, F; Lian, K; Liu, X; Meng, T; Tan, Y; Yang, X; Yu, T; Yuan, H; Zeng, Y; Zhu, Y | 1 |
| Chen, Y; Chu, M; Fu, K; Guo, Y; Han, P; Li, W; Liu, Y; Zhu, F | 1 |
| Abasi, S; Ahmadi, Z; Ashrafizadeh, M; Dehghannoudeh, G; Khanbabaei, H; Mohamadi, N; Mohammadinejad, R; Tamaddondoust, RN; Thakur, VK; Zarrabi, A | 1 |
| Cheng, J; He, J; Liu, R; Liu, Z; Yan, T | 1 |
| Chattopadhyay, S; Dey, A; Kumar, S; Manna, S; Roy, S; Saha, B | 1 |
| Nandi, S; Nayak, BS; Roy, H | 1 |
| Clement Frey, F; Eberli, D; Kletzmayr, A; Millan, C; Zimmermann, M | 1 |
| Akbari, A; Mohammadzadeh, R; Shahim, P | 1 |
| Gaware, VS; Høgset, A; Høgset, H; Iversen, TG; Masson, M; Mælandsmo, GM; Pandya, AD; Sahariah, P; Sandvig, K; Skotland, T; Øverbye, A | 1 |
| Huo, M; Liu, Y; Wang, L; Yang, M; Yin, T; Zhou, J | 1 |
| Guo, L; Li, J; Liu, X; Meng, D; Shang, M; Shi, D; Sun, X; Zhao, Y; Zhou, X | 1 |
| Aliparasti, MR; Atyabi, F; Baghaei, M; Esmaily, M; Farhadi, S; Ghalamfarsa, G; Haghnavaz, N; Jadidi-Niaragh, F; Moghadaszadeh Ardebili, S; Mohammadi, H; Nikkhoo, A; Rostami, N; Sojoodi, M; Yousefi, M | 1 |
| Chokradjaroen, C; Rujiravanit, R; Saito, N; Theeramunkong, S | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Delair, T; Li, Y; Wu, D; Xu, S; Yang, G; Zhang, X; Zhu, L | 1 |
| Chen, Y; Huang, S; Lee, I; Xuan, G; Zhang, M | 1 |
| Jayasree, RS; Jibin, K; Maiti, KK; Prasad, JS; Saranya, G; Shenoy, SJ | 1 |
| Hu, F; Jin, X; Li, S; Lian, K; Qiu, G; Yang, X; Yu, T; Yuan, H; Zeng, Y; Zhou, X | 1 |
| Aoki, S; Ayyanaar, S; Balachandran, C; Bhaskar, RC; Kesavan, MP; Raja, RP; Rajagopal, G; Rajesh, J; Webster, TJ | 1 |
| Hwang, EJ; Jeong, YI; Kim, DH; Kim, SW; Kim, T; Koh, JW; Sonntag, KC | 1 |
| Atyabi, F; Azizi, G; Baghi Moornani, M; Baradaran, B; Ghalamfarsa, G; Hajizadeh, F; Izadi, S; Jadidi-Niaragh, F; Karpisheh, V; Kiani, M; Masjedi, A; Moghadaszadeh Ardebili, S; Namdar, A; Sabz, G; Yousefi, M | 1 |
| Choi, JS; Park, JS | 1 |
| Amirani, E; Asemi, Z; Hallajzadeh, J; Mansournia, MA; Yousefi, B | 1 |
| Fu, Q; Gu, Z; Jin, X; Lv, H; Zhang, Z | 1 |
| Cheng, X; Huang, N; Li, W; Wang, J; Xu, Y | 1 |
| Kong, F; Tang, C; Yin, C | 1 |
| Abd El-Salam, HM; Ahmed, OM; Kamel, EM | 1 |
| Kim, K; Kwon, IC; Ryu, JH; Sun, IC; Yoon, HY | 1 |
| Asemi, Z; Eslahi, M; Hallajzadeh, J; Mansournia, MA; Sadoughi, F; Yousefi, B | 1 |
| Efthimiadou, EK; Mavromoustakos, T; Metaxa, AF; Vrontaki, E | 1 |
| Abdpoor Sough, TS; Atyabi, F; Edalati, M; Fakkari Afjadi, J; Haeri, MS; Hajiramezanali, M; Hajizadeh, F; Heydarzadeh Asl, S; Izadi, S; Jadidi-Niaragh, F; Karpisheh, V; Masjedi, A; Mirzazadeh Tekie, FS; Nabi Afjadi, M; Sojoodi, M | 1 |
| Li, Q; Liu, Z; Meng, Z; She, J; Zhang, R; Zhang, Y; Zhou, X; Zhu, W | 1 |
| Muanprasat, C; Satitsri, S | 1 |
| Ouyang, S; Saeed, AFUH; Su, J | 1 |
| Bauer, AT; Failla, AV; Gorzelanny, C; Goycoolea, FM; Hoffmann, S; John, A; Osorio-Madrazo, A; Schmage, P; Schneider, SW; Vidal-Y-Sy, S; von Palubitzki, L; Wang, Y; Zobiak, B | 1 |
| Fu, J; Houzong, R; Kong, X; Ma, Y; Shao, K; Shi, J; Wang, L | 1 |
| Guarve, K; Kriplani, P | 1 |
| Ashrafi, B; Nikbakht, MR; Rashidipour, M; Soroush, S; Taherikalani, M; Veiskarami, S | 1 |
| Binks, BP; Chen, K; Qian, Y; Qiu, X; Wang, C; Yang, D | 1 |
| Kong, Y; Li, X; Liu, W; Liu, X; Mu, X; Pang, J | 1 |
| Ashrafizadeh, M; Azami, N; Bagherian, M; Delfi, M; Farahani, MV; Hamblin, MR; Hamzehlou, S; Hashemi, F; Hushmandi, K; Makvandi, P; Saleki, H; Sharifzadeh, SO; Varma, RS; Zabolian, A; Zarrabi, A | 1 |
| Alfaifi, MY; Elbehairi, SEI; Elshaarawy, RFM; Hafez, HS; Ismail, LA | 1 |
| A, A; Grøndahl, L; Li, L; Mushtaq, A | 1 |
| Ahmadi Nasab, N; Hemmati, K; Hesaraki, S; Nezafati, N | 1 |
| Bishayee, A; Gupta, A; Loka, M; Pandey, AK; Singh, AK | 1 |
| Barbosa, MA; Castro, F; Gonçalves, RM; Lima, BV; Oliveira, MJ | 1 |
| Irani, M; Shikhi-Abadi, PG | 1 |
| Li, Z; Lv, X; Mohammadniaei, M; Sun, Y; Wang, W; Zhang, M; Zhang, Q; Zhou, N | 1 |
| Liu, T; Su, G; Xu, B; Xu, Y; Yang, H; Yu, Y | 1 |
| Abnous, K; Bahrami, AR; Danesh, NM; Khatami, F; Matin, MM; Taghdisi, SM | 1 |
| Abd El-Aty, AM; Li, C; Ma, C; Ren, D; Wang, J; Zhai, X | 1 |
| Ahmed, J; Alshehri, SM; Gandhi, S; Kesarwani, V; Shahdeo, D; Suhag, D | 1 |
| Chen, J; Du, Q; Huang, J; Lv, F; Tang, X; Zhao, Z | 1 |
| Hassanzadeh-Tabrizi, SA; Koupaei, N; Salmanian, G | 1 |
| Daniels, A; Mokhosi, S; Ramnandan, D; Singh, M | 1 |
| Gong, X; Han, Y; Liang, N; Pan, J; Sun, S | 1 |
| Guo, Y; Li, C; Li, L; Sun, K; Zhang, P | 1 |
| Gong, X; Li, S; Liang, N; Liu, J; Shi, H; Sun, S; Yan, P | 1 |
| Ataklti, GY; Choi, J; Doan, VHM; Ly, CD; Mondal, S; Nguyen, VT; Oh, J; Park, S; Vo, TMT; Vu, DD | 1 |
| Balan, V; Dodi, G; Mihai, CT; Serban, AM; Ursachi, VC | 1 |
| Chen, J; Li, Q; Tang, C; Yin, C; Zhang, L | 1 |
| Martins, A; Oliveira, C; Reis, RL; Silva, TH | 1 |
| Correia, A; Figueiredo, P; Fontana, F; Guedes, G; Hietala, S; Lindén, J; Pinto, RJB; Santos, HA; Sousa, FL; Wang, S | 1 |
| Alfaifi, MY; Elbehairi, SEI; Elshaarawy, RFM; Kamal, I; Khedr, AIM; Saad, AS | 1 |
| Chen, Y; Chen, Z; Geng, Y; Li, S; Li, T; Liu, Y; Shen, X; Wu, C; Xie, X; Yang, H | 1 |
| Babu, A; Ramesh, R | 1 |
| Kim, HC; Kim, K; Kim, MJ; Kim, SH; Ku, SH; Kwon, IC; Lee, JH; Lee, SJ | 1 |
| Chen, Z; Gu, N; Han, X; Jia, HR; Jiang, YW; Li, YH; Liu, P; Wang, HY; Wu, FG; Yu, ZW; Zhu, YX | 1 |
| Cho, HJ; Kim, DD; Kim, DH; Kim, JS; Lee, JY; Lee, MY; Lee, SY; Termsarasab, U | 1 |
| Cheng, X; Fu, S; Tang, R; Wang, X; Yang, G; Yao, W; Zha, Q | 1 |
| Chen, Y; Feng, S; Gao, F; Liu, W; Wu, J | 1 |
| He, L; Tang, R; Wang, J; Wang, X; Wei, B; Yan, GQ | 1 |
| Cheng, L; Fan, Q; Hao, T; Li, D; Lv, H; Ma, H; Peng, J; Shao, M; Zhao, C; Zong, X | 1 |
| Chen, H; Gao, Y; Li, Z; Lv, T; Xie, X; Zhang, H; Zhang, Y | 1 |
| Dong, X; Du, J; Gu, Z; Guo, Z; Liu, X; Xie, J; Yong, Y; Zhang, C; Zhang, G; Zhao, Y | 1 |
| Dong, X; Leng, X; Sun, Z; Wang, X | 1 |
| Guo, Y; He, Y; Kong, M; Shang, L; Song, Q; Tan, S; Wu, T; Yin, Y; Zhang, D; Zhang, Z; Zhao, Y | 1 |
| Cheung, PCK; Qiu, WY; Wang, YY; Wu, LX; Yan, JK | 1 |
| Cha, B; Choi, C; Jeong, GW; Jeong, YI; Jung, YH; Kang, DH; Kwak, TW; Lee, HL; Nah, JW; Song, YH | 1 |
| Mahmoudzadeh, A; Mohammadpour, H | 1 |
| Chang, H; Han, H; Jeon, S; Kim, JH; Kim, K; Ko, H; Kwon, IC; Lee, H; Min, J; Na, JH; Park, JH; Shim, MK; Suh, M; Yhee, JY; Yoon, HY | 1 |
| Shi, Y; Su, C; Zhao, L; Zheng, Y | 1 |
| Castanares, MA; Collins, DS; Hyun, H; Park, J; Pei, Y; Yeo, Y | 1 |
| Abu El-Naaj, I; Bianco-Peled, H; Ghantous, Y; Goldfeder, M; Prinz, H; Schroeder, A; Shainsky, J; Shtenberg, Y | 1 |
| Bharathiraja, S; Bui, NQ; Kim, H; Lee, KD; Manivasagan, P; Mondal, S; Moorthy, MS; Oh, J; Phuoc, NT; Seo, H; Vy Phan, TT | 1 |
| Fu, S; Wu, J; Xia, J | 1 |
| Chatterjee, B; Ghosh, SS; Raza, A | 1 |
| Han, SS; Kumar, A; Rao, KM; Suneetha, M | 1 |
| Gan, Z; He, F; Long, P; Su, H; Xiang, K; Xu, M; Yu, Q; Zhang, J; Zhang, X | 1 |
| Chi, Z; Han, D; Jiang, F; Li, J; Liu, C; Yu, L | 1 |
| Gwon, HJ; Heo, H; Jang, MK; Jeong, SI; Kim, EJ; Lim, YM; Park, JS; Park, SC; Park, SJ | 1 |
| Chiriac, H; Danceanu, C; Herea, DD; Labusca, LS; Lupu, N; Radu, E | 1 |
| Jeong, YY; Lee, BI; Moon, MJ; Park, HJ; Park, IK; Surendran, SP; Thomas, RG | 1 |
| Becker, J; Herance, JR; Luy, B; Pineda-Lucena, A; Schätzlein, MP; Schulze-Sünninghausen, D | 1 |
| Ding, YF; Huang, Q; Li, S; Liang, L; Wang, LH; Wang, R; Yang, W; Yuwen, L | 1 |
| Cao, QR; Chen, LQ; Cui, JH; Huang, HY; Jin, H; Lee, BJ; Li, B; Liu, Y; Zhang, XX | 1 |
| He, L; Tang, R; Wang, J; Wang, X; Wei, B; Yan, G | 1 |
| Barar, J; Erfan-Niya, H; Fathi, M; Majidi, S; Omidi, Y; Zangabad, PS | 1 |
| Ahmad, N; Ahmad, R; Alam, MA; Jalees Ahmad, F; Umar, S | 1 |
| Costa, DF; Torchilin, VP | 1 |
| Asl, SS; Hajibabaei, F; Moghadam, AH; Moghadam, NH; Rakhtshah, J; Saidijam, M; Salehzadeh, S; Sharifinia, S; Tanzadehpanah, H | 1 |
| He, X; Wang, H | 1 |
| Jia, C; Ren, T; Sun, H; Tan, X; Yang, Z; Zhang, Y | 1 |
| Ge, C; Li, Q; Lin, S; Luo, M; Nan, K; Wang, D; Wang, J | 1 |
| Sutar, YB; Telvekar, VN | 1 |
| Dai, S; Hu, F; Liu, X; Liu, Y; Meng, T; Tan, Y; Wen, L; Yang, X; Yu, F; Yuan, H; Zhu, Y | 1 |
| Amini, M; Arefian, E; Atyabi, F; Dinarvand, M; Dinarvand, R; Soleimani, M; Tekie, FSM; Zakerian, A | 1 |
| Chokradjaroen, C; Rujiravanit, R; Saito, N; Theeramunkong, S; Yui, H | 1 |
| Li, J; Liu, P | 1 |
| Chen, WR; Doughty, A; Liu, H; Nag, OK; Saha, LC | 1 |
| Muangnoi, C; Ratnatilaka Na Bhuket, P; Rojsitthisak, P; Sorasitthiyanukarn, FN | 1 |
| Banik, N; Hussain, A; Khatun, B; Maji, T; Ramteke, A | 1 |
| Armesilla, AL; Focarete, ML; Gupta, A; Khalaf, T; Khalil, IR; Khechara, MP; Kowalczuk, M; Kurusamy, S; Mendrek, B; Radecka, I; Scandola, M | 1 |
| Batgerel, T; Jeong, YY; Kim, CS; Park, CH; Ramachandra Kurup Sasikala, A; Thomas, RG; Unnithan, AR | 1 |
| Du, B; Ma, L; Wang, L; Weng, W; Xin, C; Yang, W; Yao, X | 1 |
| Dai, Y; Gai, S; He, F; Li, W; Liu, S; Suh, YD; Yang, G; Yang, P; Zhong, C | 1 |
| Chu, K; Guo, Y; Han, L; Li, T; Ouyang, H; Qiu, L; Wang, X; Xu, W | 1 |
| Barreto, GE; Fereydouni, N; Johnston, TP; Nemati, S; Saheb, M; Sahebkar, A | 1 |
| Ashraf, SM; Jaleel, JA; Pramod, K; Rathinasamy, K | 1 |
| Edison, TNJI; Kumar, P; LewisOscar, F; Pugazhendhi, A; Shanmugam, S; Shanmuganathan, R | 1 |
| Abuelmakarem, HS; Ahmed, WA; El-Azab, J; Farghaly, MMA; Sliem, MA | 1 |
| Esmaeily, A; Hakimi, S; Mohammadi, Z; Mortazavian, E; Nazari, M; Rahmani, S; Samadi, FY; Tehrani, MR; Tehrani, NR | 1 |
| Amanlou, M; Bigdeli, B; Dehghani, S; Goliaei, B; Hosseini, M; Khoobi, M; Lotfabadi, A; Naeimi, H; Nejadshafiee, V; Nezamtaheri, MS; Sadighi, A; Sharifzadeh, M | 1 |
| Ding, X; Han, J; Luo, T; Pan, X; Tian, B; Zhang, J; Zhao, F | 1 |
| Asghar, S; Dai, S; Feng, S; Jin, L; Shao, F; Wang, Y; Xiao, Y; Xu, M | 1 |
| Cao, J; Cheng, M; Gao, X; Liu, Y; Niu, X; Wang, W; Yuan, Z; Zhang, Y | 1 |
| Calixto, GMF; Chorilli, M; de Annunzio, SR; Ferreira, PS; Fontana, CR; Frade, ML; Victorelli, FD | 1 |
| Li, K; Li, P; Liu, S; Qin, Y; Xing, R; Zhang, E | 1 |
| Sun, JZ; Sun, L; Sun, YC | 1 |
| Choi, Y; Kim, BS; Kim, K; Kwon, IC; Lim, S; Yoon, HY | 1 |
| Ding, YF; Li, S; Pan, YT; Wang, LH; Wang, R; Wei, J | 1 |
| Chen, XM; Fu, Q; Liu, SY; Lv, PP; Ma, GH; Wei, W; Yue, H; Yue, ZG | 1 |
| Du, Y; Hu, F; Li, C; Liu, F; Wang, Z; You, J; Yuan, H; Zhang, P; Zhou, J | 1 |
| Chen, D; Chen, WR; Du, N; Gu, Y; Hode, T; Li, X; Min, M; Naylor, M; Nordquist, RE | 1 |
| Jiang, X; Wang, J; Wang, X; Wu, W; Zhang, J; Zhen, X | 1 |
| Choi, JW; Kang, E; Kim, SW; Kwon, OJ; Yun, CO | 1 |
| Che, X; Liu, P; Liu, Y; Lu, L; Wu, J; Xie, X; Xu, X; Yu, H; Yu, J | 1 |
| Han, L; Tang, C; Yin, C | 2 |
| Gao, Z; Huang, W; Jia, L; Jin, M; Li, Y; Liu, S; Wang, Y; Yang, F | 1 |
| Lin, FH; Lin, JC; Lin, TC | 2 |
| Guo, A; Guo, S; Jiang, J; Li, M; Li, Y; Liu, J; Lv, L; Shen, Y; Wang, F; Xu, X | 1 |
| Choi, K; Huh, KM; Kim, K; Kwon, IC; Lee, YK; Li, L; Min, HS; Oh, IH; Tran, TH | 1 |
| Chang, J; Duan, Y; Li, X; Li, Z; Liang, X | 1 |
| Liu, Y; Yu, D; Zhang, L; Zhangl, N | 1 |
| Kashanian, S; Khodaei, MM; Peyman, H; Roshanfekr, H | 1 |
| Choi, WI; Kim, JY; Kim, M; Tae, G | 1 |
| Ge, Y; Guo, X; Jin, Y; Kong, F; Shen, H; Shen, S; Wang, X; Wu, L; Xie, M | 1 |
| Gong, R; Huang, F; Qiu, Y; Wang, J; Zheng, M; Zhu, J | 1 |
| Chen, X; Han, J; Jia, X; Ma, J; Ma, Z | 1 |
| Ahn, CH; Choi, K; Jeong, SY; Kim, DE; Kim, K; Kwon, IC; Na, JH; Sun, IC | 1 |
| Huang, CH; Nwe, K; Tsourkas, A | 1 |
| Chougule, MB; Tekade, RK | 1 |
| Chen, J; Fang, M; Huang, L; Lai, H; Lu, C; Luo, X; Zhang, Q | 1 |
| Guo, Y; Jia, M; Liu, Y; Shang, J; Wu, D; Xu, J; Zeng, Y; Zhang, S | 1 |
| Alexandrov, M; Ignatova, M; Kalinov, K; Manolova, N; Rashkov, I; Toshkova, R | 1 |
| Banerjee, S; Chattopadhyay, A; Ghosh, SS; Sahoo, AK | 1 |
| Chen, Z; Cui, W; Liu, L; Song, H; Su, C; Zhao, L; Zhu, B | 1 |
| Agarwal, P; He, X; Lei, Y; Li, C; Lu, X; Poventud-Fuentes, I; Rao, W; Wang, Y; Weekes, B; Yu, J; Zhang, W | 1 |
| Gu, CH; Lang, MD; Le, VM; Liu, JW; Lu, YH; Shi, WB; Zheng, YH | 1 |
| Chen, H; Cui, Y; Fang, W; Wang, Z; Zhong, Y; Zhu, D; Zong, S | 1 |
| Liu, K; Lv, H; Mao, Y; Zhao, W; Zhu, M; Zhu, Q | 1 |
| Gomathi, T; Govindarajan, C; Imran, PK; Kim, SK; Rose H R, MH; Sudha, PN; Venkatesan, J | 1 |
| Bai, Q; Deng, Z; Liu, C; Liu, J; Lou, W; Ma, J; Wang, S; Xu, H; Xu, L; Zhang, D | 1 |
| Du, B; Duan, R; Guan, M; Liu, L; Su, G; Zhang, Q; Zhou, Z | 1 |
| Guo, L; Li, Y; Lu, W; Wang, X; Yan, B; Yan, DD; Yang, D; Zalewski, O | 1 |
| Hu, A; Kumar, DA; Madhusudhan, A; Natarajan, S; Reddy, GB; Singh, SS; Veerabhadram, G; Venkatesham, M; Yang, MY | 1 |
| An, SW; Cho, HJ; Ki, MH; Kim, DD; Kim, JE; Lee, YN; Noh, SM | 1 |
| Bao, N; Gu, H; Gu, W; Wang, Q; Yu, C; Zhu, Z | 1 |
| Kwag, DS; Lee, ES; Oh, KT | 1 |
| Gunduz, U; Khodadust, R; Mutlu, P; Onguru, O; Unsoy, G; Yalcin, S | 1 |
| Chen, Y; Dahmani, FZ; Wang, X; Yao, J; Yin, L; Zhou, J | 1 |
| Chen, M; Ping, Q; Qiao, H; Su, Z; Sun, M; Xie, Y | 1 |
| Bao, X; Ding, Y; Jin, Y; Wang, C; Wang, W; Wang, X; Wang, Y; Zhou, J | 1 |
| Dang, Y; Gao, C; Guo, J; He, G; Kong, X; Liu, T; Wang, W; Yin, Y; Yu, Z; Zhang, X; Zheng, H | 1 |
| Lin, YC; Lou, PJ; Young, TH | 1 |
| Bhunchu, S; Rojsitthisak, P | 1 |
| Correia, IJ; Costa, EC; Gaspar, VM; Pichon, C; Queiroz, JA; Sousa, F | 1 |
| Chen, X; Ma, HL; Pei, JJ; Wang, ZB; Wu, JY; Yan, JK | 1 |
| Kim, K; Kim, SH; Ku, SH; Kwon, IC; Lee, SJ; Min, HS; Son, S | 1 |
| Abbaspour-Aghdam, F; Anarjan, N; Berenjian, A; Ghaz-Jahanian, MA; Jafarizadeh-Malmiri, H | 1 |
| Prabaharan, M | 1 |
| Jeong, JH; Jeong, SY; Kim, K; Kim, KS; Kim, MG; Kim, SH; Koo, H; Kwon, IC; Lee, SJ; Park, SG; Son, S; Song, S; Yhee, JY | 1 |
| Lee, A; Park, K; Park, OK; Rhee, JK; Yang, DH | 1 |
| Chennazhi, KP; Jayakumar, R; Jeong, YY; Manzoor, K; Muthiah, M; Park, IK; Sanoj Rejinold, N; Thomas, RG | 1 |
| Huang, WH; Jin, ZH; Li, Y; Pei, Y; Wang, XY; Wang, Y; Xiao, YS; Xie, M; Zhang, LN | 1 |
| Alayoubi, A; Alqahtani, S; Astete, CE; Kaddoumi, A; Nazzal, S; Sabliov, CM; Shen, Y; Simon, L; Sylvester, PW; Xu, Z | 1 |
| Chen, Z; Fu, Q; Lv, P; Ma, G; Ni, D; Wei, W; Yue, H; Yue, Z; Zhang, L | 1 |
| Bin, J; Chen, Y; Deng, YL; Jiang, G; Le, DE; Li, M; Liao, Y; Lin, ZT; Liu, Y; Wang, H; Xiao, Y | 1 |
| Du, Y; He, J; Hu, F; Hu, Y; Huang, X; Su, Y; You, J; Yuan, H | 1 |
| Cai, B; Chen, Z; Cheng, H; He, J; Li, W; Song, Y; Wu, L; Xiao, Y; Zhang, L; Zhao, C | 1 |
| Chen, AZ; Chen, WG; Kang, YQ; Liu, YG; Wang, SB; Wu, WG; Ye, SF; Zhang, R | 1 |
| Danilova, NV; Eliseeva, MY; Kalzhanov, ZR; Kosmas, IP; Mal'kov, PG; Mynbaev, OA; Nefedova, NA | 1 |
| Chen, HL; Chia, WT; Chiu, YL; Chuang, EY; Hsiao, CW; Korupalli, C; Liao, ZX; Lin, KJ; Sung, HW; Wan, D | 1 |
| Hou, Z; Li, Y; Lin, C; Lin, J; Luo, F; Wu, H; Xie, L; Yu, F; Zhou, S | 1 |
| Mohanraj, R; Subha, S | 1 |
| Chen, X; Huang, Y; Shi, S; Weng, J; Zheng, N | 1 |
| Choi, JW; Lee, KJ; Nah, JW; Nam, JP; Yun, CO | 1 |
| Bheemanapally, K; Botlagunta, M; Kakarla, L; Mathi, P; Othayoth, R | 1 |
| Lai, WF; Lin, MC | 1 |
| Deng, P; Feng, R; Song, Z; Teng, F | 1 |
| Nah, JW; Nam, JP | 1 |
| de Carvalho, SM; Mansur, AA; Mansur, HS | 1 |
| Mo, R; Qu, D; Xu, X; Xue, L; Zhang, C; Zhang, N; Zhang, X | 1 |
| Feng, B; Liu, M; Shi, Y; Su, C; Yang, G; Yu, X; Zhao, L | 1 |
| Jeon, S; Kim, K; Kwon, IC; Lee, S; Min, HS; Park, JH; Son, S; You, DG | 1 |
| Corbet, C; Feron, O; Marchand-Brynaert, J; Pourcelle, V; Préat, V; Ragelle, H; Vanvarenberg, K | 1 |
| Hatakeyama, H; Lopez-Berestein, G; Mangala, LS; Sood, AK; Wu, SY | 1 |
| Firuzi, O; Hamidi, M; Miri, R; Mohammadi-Samani, S; Rostamizadeh, K; Sadighian, S; Zarrin, A | 1 |
| Kang, HW; Lee, N; Oh, J; Oh, Y | 1 |
| Chen, HP; Chen, MH; Liu, TY; Tung, FI | 1 |
| Li, W; Meng, Y; Suarato, G | 1 |
| Amini, M; Darvishi, MH; Dinarvand, R; Hashemzadeh, H; Nomani, A; Shokrgozar, MA | 1 |
| Cheng, F; Cheng, J; He, J; Huang, Y; Li, D; Li, J; Yan, T | 1 |
| Chen, XZ; Hoop, M; Hurter, C; Mushtaq, F; Nelson, BJ; Pané, S | 1 |
| Chowdhuri, AR; Ghosh, SK; Sahu, SK; Singh, T | 1 |
| Arjunan, N; Kandasamy, J; Kandasamy, R; Kumari, HL; Singaravelu, CM | 1 |
| Chen, X; Dai, Y; Li, C; Li, N; Liu, Q; Lu, Y; Qiu, Z; Ren, S; Tian, F; Wang, X; Xing, H; Zhou, S | 1 |
| Chang, H; Choi, K; Choi, Y; Jang, GH; Kim, K; Kwon, IC; Lee, KH; Na, JH; Park, JH; Ryu, JH; Yhee, JY; You, DG | 1 |
| Calhelha, RC; Conceição, DS; Ferreira, DP; Ferreira, ICFR; Socoteanu, R; Sousa, T; Vieira Ferreira, LF | 1 |
| Cai, C; Cheng, J; Cheng, M; Deng, J; Wu, S; Zhou, H | 1 |
| Mitjans, M; Nogueira-Librelotto, DR; Rolim, CMB; Scheeren, LE; Vinardell, MP | 1 |
| Bai, Y; Chan, L; Chen, L; Chen, T; Liu, Z | 1 |
| Afzal, M; Alamgir, K; Bano, S; Nazir, S; Waraich, MM | 1 |
| Cocco, E; Coman, D; Hoque, SM; Huang, Y; Hyder, F; Maritim, S; Santin, AD; Shapiro, EM | 1 |
| Ji, J; Liu, A; Yang, X; Zhai, G; Zhang, X | 1 |
| Cui, W; Du, C; Duan, L; Li, J; Qi, W; Shao, J; Xuan, M; Zhao, J | 1 |
| Anandhakumar, S; Krishnamoorthy, G; Raichur, AM; Ramkumar, KM | 1 |
| Atyabi, F; Bahrainian, S; Dinarvand, R; Saber, MM | 1 |
| Isaei, E; Mohammadi, Z; Samadi, FY; Sedghi, R; Shaabani, A | 1 |
| Acquaviva, C; Braendlein, M; Ferro, M; Lopresti, A; Malliaras, GG; Mamessier, E; Owens, RM; Pappa, AM | 1 |
| Carvalho, MR; Costa, BM; Maia, FR; Oliveira, JM; Reis, RL; Silva-Correia, J | 1 |
| Chen, J; He, G; Huang, Z; Yan, Q; Yi, X; Yin, Y; Zeng, T; Zhang, L; Zhang, Y | 1 |
| Kamath, PR; Sunil, D | 1 |
| Bharathiraja, S; Manivasagan, P; Oh, J; Oh, YO; Quang Bui, N; Santha Moorthy, M; Seo, H; Song, K; Yoon, M | 1 |
| Han, H; Kim, H; Kim, K; Koo, H; Kwon, IC; Lee, H; Lee, KE; Lee, S; Na, JH; Yoon, HY | 1 |
| Key, J; Park, K | 1 |
| Alonso, MJ; Domínguez, F; Lozano, MV; Torrecilla, D; Torres, D; Vidal, A | 1 |
| Choong, PF; Dass, CR; Tan, ML | 2 |
| Chan, HY; Chen, MH; Jeng, JH; Shen, KT; Wang, YJ | 1 |
| Jin, Y; Li, YJ; Qiu, LY; Yu, JM | 1 |
| Bora, U; Das, RK; Kasoju, N | 1 |
| Chang, SM; Chen, WS; Lin, FH; Shieh, MJ; Tsai, KC; Yang, SJ | 1 |
| Gao, JQ; Hu, YL; Liang, WQ; Lv, TF; Shuai, WP; Tabata, Y; Tang, GP; Zhao, QQ; Zhou, J | 1 |
| Chung, YI; Kim, JC; Kim, K; Kim, YH; Kwon, IC; Lee, SY; Tae, G | 1 |
| Chang, J; Gong, X; Liang, X; Niu, R; Song, T; Wang, H; Zhao, P | 1 |
| Chen, XG; Cheng, XJ; Huang, L; Sun, GZ; Zhang, J | 1 |
| Choi, K; Choi, Y; Chung, H; Huh, MS; Jeong, SY; Kim, K; Kwon, IC; Lee, S; Lee, SY; Oh, YK; Park, JH; Park, S | 1 |
| Choi, K; Han, MH; Jeong, SY; Kim, K; Kwon, IC; Leary, JJ; Lee, SY; Nam, T; Park, K; Park, S; Song, IC; Yuk, SA | 1 |
| Baik, HJ; Lee, AH; Lee, BR; Lee, ES; Oh, KT; Oh, NM; Youn, YS | 1 |
| Da Sacco, L; Masotti, A | 1 |
| Chi, D; Choi, K; Kil, H; Kim, GC; Kim, HJ; Kim, K; Kim, SY; Kwon, IC; Lee, BS; Lee, S; Oh, SJ; Park, K; Park, S | 1 |
| Hwang, T; Kang, E; Kim, JH; Kwon, OJ; Lee, JM; Park, H; Park, Y; Yun, CO | 1 |
| Gao, JQ; He, CX; Hu, CJ; Hu, YL; Li, N; Tang, GP; Zhou, J | 1 |
| Chen, Z; Deng, F; Fan, C; Fan, H; Gao, W; Li, M | 1 |
| Baik, HJ; Lee, BR; Lee, ES; Oh, KT; Oh, YT; Park, SY; Youn, YS | 1 |
| Baik, HJ; Lee, ES; Oh, KT; Oh, NM; Oh, YT; Park, SY; Yoo, NY; Youn, YS | 1 |
| Chen, X; Choi, K; Choi, Y; Jeong, SY; Kim, K; Koo, H; Kwon, IC; Leary, JF; Lee, DE; Lee, S; Lee, SJ; Min, S; Park, K | 1 |
| Ramakrishnan, S | 1 |
| Patel, JK; Patel, MP; Patel, RR | 1 |
| Jeong, SY; Kim, K; Koo, H; Kwon, IC; Lee, S; Lee, SH; Min, KH; Na, JH; Park, JH; Park, K; Yoo, H | 1 |
| Kang, E; Kim, JH; Kwon, OJ; Park, HK; Park, Y; Yun, CO | 1 |
| Dash, AK; Jain, N; Joshi, SS; Munt, DJ; Trickler, WJ | 1 |
| Chandra, R; Gupta, N; Nimesh, S | 1 |
| Choi, WI; Kim, JY; Kim, YH; Tae, G | 1 |
| Astilean, S; Baldeck, PL; Boca, SC; Gabudean, AM; Juhem, A; Potara, M | 1 |
| Ding, P; Huang, Y; Li, GY; Zhong, M; Zhong, YD; Zhou, ZD | 1 |
| Bae, SM; Choi, KY; Hoffman, AS; Kim, IS; Kim, JH; Kim, K; Kwon, IC; Lee, BH; Min, KH; Na, MH; Park, RW; Shin, H; Yang, YJ | 1 |
| Ahn, CH; Choi, K; Eun, DK; Kim, HS; Kim, K; Ko, CY; Koo, H; Kwon, IC; Sun, IC; Yi, DK | 1 |
| Bao, X; Chen, Y; Huang, A; Li, H; Li, S; Niu, J; Ping, Q; Su, Z; Sun, M; Xiao, Y | 1 |
| Mahapatro, A; Singh, DK | 1 |
| Kim, J; Kim, PH; Kim, SW; Yun, CO | 1 |
| Cho, SH; Kim, K; Kim, SY; Kwon, IC; Lee, JH; Oh, KS; Oh, S; Yuk, SH | 1 |
| Colson, YL; Grinstaff, MW; Wolinsky, JB | 1 |
| Liao, X; Zhang, X | 1 |
| Cao, C; Chen, X; Luo, F; Lv, H; Ni, E; Wang, S; Yan, J; Ye, M; Zeng, F | 1 |
| Gao, ZG; Huang, W; Li, YF; Yang, FF | 1 |
| Ju, H; Lai, G; Wang, L; Wu, J; Yan, F | 1 |
| Cheng, T; Guan, XM; Lan, JF; Liu, XY; Shen, JM; Zhang, HX | 1 |
| Kwag, DS; Lee, ES; Oh, KT; Oh, NM; Oh, YT; Youn, YS | 1 |
| Nimesh, S | 1 |
| Byun, Y; Choi, K; Choi, Y; Chu, JU; Huh, MS; Jeon, H; Jeong, SY; Kim, K; Koo, H; Kwon, IC; Lee, KE; Lee, S; Lee, SJ; Lee, SY; Min, S; Park, K | 1 |
| Huo, M; Li, J; Wang, J; Yao, C; Zhang, Q; Zhang, Y; Zhou, J; Zhu, Q; Zou, A | 1 |
| Choi, WI; Heo, SU; Jeong, YY; Kim, JY; Kim, YH; Tae, G | 1 |
| Du, YZ; Hu, FQ; You, J; Yuan, H; Zhang, YY | 1 |
| Choi, K; Cooper, C; Dhawan, D; Key, J; Kim, AY; Kim, K; Knapp, DW; Kwon, IC; Leary, JF; Park, JH; Park, K | 1 |
| Chen, WW; Du, YZ; Hu, FQ; Yuan, H; Zhao, MD | 1 |
| Campbell, C; Dwivedi, P; Garg, NK; Tyagi, RK | 1 |
| Alonso, MJ; Brea, J; Esteban, H; Loza, MI; Lozano, MV; Torres, D | 1 |
| Fernandez-Fernandez, A; Lei, T; Manchanda, R; McGoron, AJ; Srinivasan, S | 1 |
| Cao, J; Cui, S; Gu, Y; Qian, Z; Zhu, H | 1 |
| Carr, D; Church, A; Edgecombe, J; Fisher, A; Manderson, C; Pavis, H; Wilcock, A | 1 |
| Kato, Y; Machida, Y; Onishi, H | 1 |
| Glebov, V; Goroshetchenko, A; Komarov, B; Treskunov, K; Treskunova, O | 1 |
| Bernas, G | 1 |
| Bansal, K; Dhawan, S; Kaushik, R; Kumria, R; Singla, AK; Sinha, VR; Wadhawan, S | 1 |
| Agnihotri, SA; Aminabhavi, TM; Mallikarjuna, NN | 1 |
| Bałasińska, B; Rajewska, J | 1 |
| Kean, T; Roth, S; Thanou, M | 1 |
| Denkbaş, EB; Kurşaklioğlu, H; Misirli, Y; Oztürk, E | 1 |
| Aboubakar, M; Bertrand, JR; Couvreur, P; Elhamess, H; Gottikh, M; Maksimenko, A; Malvy, C; Polard, V; Villemeur, M | 1 |
| Qi, L; Xu, Z | 1 |
| Chan, P; Chung, JE; Kurisawa, M; Yang, YY | 1 |
| Bertrand, JR; Blot, E; Li, H; Lu, H; Maksimenko, A; Malvy, C; Opolon, P; Pillé, JY; Pritchard, LL; Soria, C; Soria, J; Vannier, JP | 1 |
| Varshosaz, J | 1 |
| Choi, K; Kim, IS; Kim, JH; Kim, K; Kim, SY; Kwon, IC; Lee, S; Nam, HY; Nam, YS; Park, JH; Park, K | 1 |
| Chen, XG; Li, YY; Liu, CS; Zhang, J | 1 |
| Kim, DH; Kim, KM; Kim, KN; Lee, YK | 1 |
| Dass, CR; Dunstan, DE; Ta, HT | 1 |
| Bae, SM; Jeong, SY; Jo, HG; Kim, IS; Kim, K; Kim, YS; Kwon, IC; Lee, S; Min, KH; Park, K; Park, RW | 1 |
| Hwang, HY; Kim, IS; Kim, YH; Kwon, IC | 1 |
| Choong, PF; Dass, CR | 1 |
| Block, LH; Fukumori, Y; Ichikawa, H; Tokumitsu, H | 1 |
| Fukumori, Y; Ichikawa, H; Tokumitsu, H | 1 |
| Fukumori, Y; Ichikawa, H; Shikata, F; Tokumitsu, H | 1 |
73 review(s) available for chitosan and Neoplasms
| Article | Year |
|---|---|
Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Chitosan; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms | 2022 |
Chemical Modification of Chitosan for Developing Cancer Nanotheranostics.
Topics: Biocompatible Materials; Chitosan; Humans; Nanostructures; Neoplasms; Theranostic Nanomedicine | 2022 |
Functionalized chitosan as a promising platform for cancer immunotherapy: A review.
Topics: Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Immunologic Factors; Immunotherapy; Neoplasms | 2022 |
Chitosan nanocarriers for microRNA delivery and detection: A preliminary review with emphasis on cancer.
Topics: Chitosan; Drug Carriers; Drug Delivery Systems; Genetic Therapy; Humans; MicroRNAs; Nanoparticles; Neoplasms; Polymers | 2022 |
Rationally-designed Chitosan-based Polymeric Nanomaterials According to Intrinsic Characteristics for Cancer Therapy and Theranostics: A Review.
Topics: Chitosan; Drug Delivery Systems; Humans; Nanostructures; Neoplasms; Polymers; Precision Medicine | 2023 |
Chitin and Chitosan: Prospective Biomedical Applications in Drug Delivery, Cancer Treatment, and Wound Healing.
Topics: Biocompatible Materials; Chitin; Chitosan; Drug Delivery Systems; Neoplasms; Prospective Studies; Wound Healing | 2022 |
Marine-Bioinspired Nanoparticles as Potential Drugs for Multiple Biological Roles.
Topics: Animals; Bacteria; Chitosan; Drug Delivery Systems; Fungi; Mammals; Metal Nanoparticles; Nanoparticles; Neoplasms; Noncommunicable Diseases; Pharmaceutical Preparations; Polymers | 2022 |
Application of Hydrogels as Carrier in Tumor Therapy: A Review.
Topics: Biocompatible Materials; Chitosan; Humans; Hyaluronic Acid; Hydrogels; Neoplasms | 2022 |
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
Topics: Antineoplastic Agents; Chitosan; Drug Delivery Systems; Nanoparticles; Nanotechnology; Neoplasms | 2022 |
Amygdalin: A Review on Its Characteristics, Antioxidant Potential, Gastrointestinal Microbiota Intervention, Anticancer Therapeutic and Mechanisms, Toxicity, and Encapsulation.
Topics: Alginates; Amygdalin; Antioxidants; Chitosan; Gastrointestinal Microbiome; Humans; Hydrogen Cyanide; Neoplasms; Pharmaceutical Preparations | 2022 |
Chitosan as a potential biomaterial for the management of oral mucositis, a common complication of cancer treatment.
Topics: Biocompatible Materials; Chitosan; Humans; Neoplasms; Stomatitis | 2023 |
Traversing the diverse avenues of exopolysaccharides-based nanocarriers in the management of cancer.
Topics: Chitosan; Fructans; Humans; Hyaluronic Acid; Neoplasms; Polymers | 2023 |
Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges.
Topics: Antineoplastic Agents; Biopolymers; Chitin; Chitosan; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms | 2023 |
Multi-functional chitosan-based nanoparticles for drug delivery: Recent advanced insight into cancer therapy.
Topics: Antineoplastic Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms; Tumor Microenvironment | 2023 |
Functionalized chitosan for cancer nano drug delivery.
Topics: Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms; Tumor Microenvironment | 2023 |
Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity.
Topics: Antineoplastic Agents; Cardiotoxicity; Cardiovascular Diseases; Chitosan; Heart Diseases; Humans; Neoplasms; Pharmaceutical Preparations | 2023 |
Chitosan and Quercetin: Potential Hand in Hand Encountering Tumors in Oral Delivery System.
Topics: Administration, Oral; Chitosan; Drug Delivery Systems; Humans; Neoplasms; Particle Size; Quercetin | 2019 |
Glycol Chitosan: A Water-Soluble Polymer for Cell Imaging and Drug Delivery.
Topics: Animals; Antineoplastic Agents; Chitosan; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Neoplasms; Solubility | 2019 |
Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Chitosan; Docetaxel; Drug Carriers; Humans; Hydrogen-Ion Concentration; Molecular Targeted Therapy; Nanoparticles; Neoplasms; Oxidation-Reduction; Paclitaxel; Solubility; Static Electricity; Theranostic Nanomedicine | 2020 |
Chitosan Anchored Nanoparticles in Current Drug Development Utilizing Computer-Aided Pharmacokinetic Modeling: Case Studies for Target Specific Cancer Treatment and Future Prospective.
Topics: Animals; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Development; Nanoparticles; Neoplasms | 2020 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Chitosan-based Colloidal Polyelectrolyte Complexes for Drug Delivery: A Review.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Culture Techniques; Chitosan; Drug Carriers; Genetic Therapy; HIV Infections; Humans; Insulin; Neoplasms; Polyelectrolytes; Vaccines | 2020 |
Effects of chitosan and oligochitosans on the phosphatidylinositol 3-kinase-AKT pathway in cancer therapy.
Topics: Cell Survival; Chitin; Chitosan; Drug Carriers; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Oligosaccharides; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction | 2020 |
Tumor-Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity.
Topics: Animals; Chitosan; Drug Carriers; Humans; Nanomedicine; Nanoparticles; Neoplasms | 2020 |
Chitosan and Wnt/β-catenin Signaling Pathways in Different Cancers.
Topics: Antineoplastic Agents; beta Catenin; Chitosan; Drug Delivery Systems; Humans; Neoplasms; Wnt Signaling Pathway | 2021 |
Chitin and Chitosan Derivatives as Biomaterial Resources for Biological and Biomedical Applications.
Topics: Animals; Arthropods; Biocompatible Materials; Cardiovascular Diseases; Chitin; Chitosan; Drug Carriers; Humans; Neoplasms; Nervous System Diseases | 2020 |
Marine-derived drugs: Recent advances in cancer therapy and immune signaling.
Topics: Animals; Antineoplastic Agents; Aquatic Organisms; Biological Products; Chitosan; Clinical Trials as Topic; Drug Delivery Systems; Drug Development; Drug Discovery; Humans; Immune System; Janus Kinases; Nanoparticles; Neoplasms; Signal Transduction; STAT Transcription Factors | 2021 |
Chitosan - A Potential Polymer to Prepare Anticancer Drug Delivery Systems: Patent Review.
Topics: Animals; Antineoplastic Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Neoplasms; Patents as Topic; Polymers | 2021 |
Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy.
Topics: Antineoplastic Agents; Chitosan; Drug Carriers; Drug Resistance, Neoplasm; Gene Silencing; Humans; Nanoparticles; Neoplasms; RNA, Small Interfering | 2021 |
Chitosan Nanomedicine in Cancer Therapy: Targeted Delivery and Cellular Uptake.
Topics: Animals; Antineoplastic Agents; Body Fluids; Chitosan; Drug Delivery Systems; Endocytosis; Humans; Nanomedicine; Neoplasms; Particle Size; Surface Properties | 2021 |
Ferulic acid-mediated modulation of apoptotic signaling pathways in cancer.
Topics: Animals; Apoptosis; Chitosan; Coumaric Acids; Drug Carriers; Gene Expression Regulation, Neoplastic; Humans; Nanoparticles; Neoplasm Proteins; Neoplasms; Polyphosphates; Signal Transduction | 2021 |
Immunomodulatory potential of chitosan-based materials for cancer therapy: a systematic review of
Topics: Chitosan; Gels; Immunomodulation; Nanoparticles; Neoplasms; Tumor Microenvironment | 2021 |
A review on the applications of electrospun chitosan nanofibers for the cancer treatment.
Topics: Antineoplastic Agents; Chitosan; Drug Delivery Systems; Humans; Nanofibers; Neoplasms; Porosity; Quality of Life | 2021 |
The impact of chitooligosaccharides and their derivatives on the in vitro and in vivo antitumor activity: A comprehensive review.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chitin; Chitosan; Humans; Neoplasm Metastasis; Neoplasms; Oligosaccharides | 2021 |
Magnetic chitosan nanocomposites for simultaneous hyperthermia and drug delivery applications: A review.
Topics: Antineoplastic Agents; Chitosan; Combined Modality Therapy; Drug Delivery Systems; Humans; Hyperthermia, Induced; Magnetic Phenomena; Nanocomposites; Neoplasms | 2021 |
Biotinylated chitosan macromolecule based nanosystems: A review from chemical design to biological targets.
Topics: Biotin; Biotinylation; Chitosan; Drug Delivery Systems; Humans; Macromolecular Substances; Molecular Imaging; Nanostructures; Nanotechnology; Neoplasms | 2021 |
Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.
Topics: Animals; Antineoplastic Agents; Chitosan; Drug Delivery Systems; Gene Transfer Techniques; Genetic Therapy; Humans; Neoplasms | 2017 |
Functional Chitosan Nanoparticles in Cancer Treatment.
Topics: Chitosan; Drug Carriers; Humans; Nanoparticles; Neoplasms | 2016 |
Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer.
Topics: Animals; Chitosan; Drug Delivery Systems; Humans; Molecular Targeted Therapy; Neoplasms; Theranostic Nanomedicine; Tumor Microenvironment | 2018 |
Micelle-like nanoparticles as siRNA and miRNA carriers for cancer therapy.
Topics: Animals; Cell Line, Tumor; Chitosan; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Models, Animal; Drug Delivery Systems; Humans; Micelles; MicroRNAs; Nanoparticles; Neoplasms; Polyamines; Polyethyleneimine; Polylysine; RNA, Small Interfering | 2018 |
Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects.
Topics: Animals; Biological Availability; Chitosan; Curcumin; Drug Carriers; Humans; Nanoparticles; Neoplasms | 2019 |
Chitosan nanopolymers: An overview of drug delivery against cancer.
Topics: Acetylation; Animals; Antineoplastic Agents; Biopolymers; Chitin; Chitosan; Combined Modality Therapy; Drug Carriers; Drug Delivery Systems; Drug Evaluation, Preclinical; Gene Transfer Techniques; Humans; Molecular Structure; Nanoparticles; Nanotechnology; Neoplasms; Theranostic Nanomedicine | 2019 |
Chitosan-Based Drug Delivery Systems for Optimization of Photodynamic Therapy: a Review.
Topics: Bacterial Infections; Chitosan; Drug Delivery Systems; Humans; Mycoses; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polysaccharides | 2019 |
Advances in chitosan-based nanoparticles for oncotherapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Liberation; Humans; Nanoparticles; Neoplasms | 2019 |
Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics.
Topics: Animals; Antineoplastic Agents; Chitosan; Drug Carriers; Drug Resistance, Neoplasm; Gene Transfer Techniques; Nanoparticles; Neoplasms | 2019 |
Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine.
Topics: Adjuvants, Immunologic; Animals; Cancer Vaccines; Chitin; Chitosan; Humans; Neoplasms | 2013 |
Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy.
Topics: Animals; Antineoplastic Agents; Cell Line; Chitosan; Drug Carriers; Genetic Therapy; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Mice; Microscopy, Confocal; Molecular Weight; Nanomedicine; Nanoparticles; Neoplasms; Permeability; Photochemotherapy; RNA, Small Interfering; Serum Albumin | 2014 |
Application of chitosan-based nanocarriers in tumor-targeted drug delivery.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Chitosan; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms | 2015 |
Chitosan-based nanoparticles for tumor-targeted drug delivery.
Topics: Animals; Chitosan; Cross-Linking Reagents; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms; Surface-Active Agents | 2015 |
Glycol chitosan-based fluorescent theranostic nanoagents for cancer therapy.
Topics: Animals; Chitosan; Diagnostic Imaging; Fluorescent Dyes; Humans; Nanoparticles; Neoplasms | 2014 |
Recent Development of Copolymeric Delivery System for Anticancer Agents Based on Cyclodextrin Derivatives.
Topics: Acrylic Resins; Antineoplastic Agents; Chitosan; Cyclodextrins; Drug Delivery Systems; Humans; Hydrophobic and Hydrophilic Interactions; Neoplasms; Polyethylene Glycols; Polymers | 2016 |
Role of pH-responsiveness in the design of chitosan-based cancer nanotherapeutics: A review.
Topics: Antineoplastic Agents; Biocompatible Materials; Chitosan; Drug Carriers; Drug Resistance, Neoplasm; Humans; Hydrogen-Ion Concentration; Nanoparticles; Neoplasms | 2016 |
Tumor targeting strategies for chitosan-based nanoparticles.
Topics: Antineoplastic Agents; Carbohydrate Sequence; Chitosan; Drug Delivery Systems; Humans; Models, Biological; Molecular Targeted Therapy; Nanoparticles; Neoplasms; Tumor Microenvironment | 2016 |
Recent progresses in layer-by-layer assembled biogenic capsules and their applications.
Topics: Alginates; Antineoplastic Agents; Biological Products; Capsules; Chitosan; Drug Carriers; Glucose Oxidase; Hemoglobins; Humans; Nanocapsules; Neoplasms; Polysaccharides; Schiff Bases; Serum Albumin | 2017 |
Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Nanoparticles; Neoplasms; Particle Size | 2017 |
Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy.
Topics: Animals; Chitosan; Combined Modality Therapy; Drug Carriers; Drug Delivery Systems; Early Detection of Cancer; Humans; Molecular Imaging; Multimodal Imaging; Nanomedicine; Nanoparticles; Nanotechnology; Neoplasms | 2017 |
Cancer, chitosan nanoparticles and catalytic nucleic acids.
Topics: Animals; Chitosan; DNA, Catalytic; Drug Compounding; Genetic Therapy; Humans; Nanoparticles; Neoplasms; RNA, Small Interfering | 2009 |
Review: doxorubicin delivery systems based on chitosan for cancer therapy.
Topics: Animals; Antibiotics, Antineoplastic; Chitosan; Doxorubicin; Drug Carriers; Humans; Molecular Structure; Nanoparticles; Neoplasms; Technology, Pharmaceutical | 2009 |
Chitin and chitosan as multipurpose natural polymers for groundwater arsenic removal and AS2O3 delivery in tumor therapy.
Topics: Arsenates; Arsenic; Arsenic Trioxide; Arsenicals; Arsenites; Chitin; Chitosan; Drug Carriers; Humans; Nanotechnology; Neoplasms; Oxides; Polymers; Water Pollutants, Chemical; Water Purification | 2010 |
Chitosan mediated targeted drug delivery system: a review.
Topics: Adhesiveness; Animals; Antineoplastic Agents; Biological Availability; Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Neoplasms; Pharmaceutical Preparations | 2010 |
Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines.
Topics: Chitosan; Cyanoacrylates; Gelatin; Humans; Lactic Acid; Nanocapsules; Neoplasms; Particle Size; Pharmaceutical Vehicles; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Vaccines | 2011 |
Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.
Topics: Adenoviridae; Animals; Biocompatible Materials; Chitosan; Genetic Therapy; Humans; Ligands; Liposomes; Methacrylates; Mice; Neoplasms; Oligopeptides; Peptides; Polyethylene Glycols; Polyethyleneimine; Polylysine; Polymers | 2012 |
Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers.
Topics: Antineoplastic Agents, Phytogenic; Biocompatible Materials; Chitosan; Decanoic Acids; Drug Delivery Systems; Gels; Humans; Microspheres; Nanoparticles; Neoplasms; Paclitaxel; Polyesters; Polymers | 2012 |
[Current status of non-viral vectors for siRNA delivery].
Topics: Animals; Cell-Penetrating Peptides; Chitosan; Drug Carriers; Genetic Vectors; Half-Life; Humans; Imines; Liposomes; Neoplasms; Polyethylenes; RNA Interference; RNA, Small Interfering; Transfection | 2011 |
Recent patents in siRNA delivery employing nanoparticles as delivery vectors.
Topics: Animals; Cations; Chitosan; Gene Transfer Techniques; Humans; Lipids; Liposomes; Mice; Nanoparticles; Neoplasms; Patents as Topic; Peptides; Polyethyleneimine; RNA, Small Interfering | 2012 |
N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates.
Topics: Animals; Antineoplastic Agents; Chitin; Chitosan; Drug Carriers; Humans; Neoplasms; Solubility; Tissue Distribution; Treatment Outcome | 2004 |
Angiotherapeutics from natural products: from bench to clinics?
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Biological Products; Chitin; Chitosan; Drug Evaluation, Preclinical; Forecasting; Humans; Ischemia; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Rabbits | 2003 |
Chitosan microspheres as a potential carrier for drugs.
Topics: Animals; Chitin; Chitosan; Drug Carriers; Humans; Hypertension; Infections; Microspheres; Neoplasms | 2004 |
Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
Topics: Chemical Precipitation; Chitosan; Drug Delivery Systems; Emulsions; Genetic Therapy; Micelles; Nanostructures; Neoplasms | 2004 |
[Biologically active compounds of edible mushrooms and their beneficial impact on health].
Topics: Adjuvants, Immunologic; Agaricales; Anticholesteremic Agents; Antineoplastic Agents; beta-Glucans; Cardiovascular Diseases; Chitosan; Cholesterol, LDL; Free Radicals; Humans; Neoplasms; Nutritive Value; Phytotherapy; Plant Preparations; Polysaccharides | 2004 |
The promise of chitosan microspheres in drug delivery systems.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Chitosan; Drug Administration Routes; Drug Delivery Systems; Embolization, Therapeutic; Humans; Magnetic Resonance Imaging; Microspheres; Neoplasms; Peptides; Prostheses and Implants; Proteins; Tissue Engineering; Vaccination | 2007 |
Injectable chitosan hydrogels for localised cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Drug Carriers; Hydrogels; Hydrogen-Ion Concentration; Injections, Intralesional; Mice; Neoplasms; Temperature; Ultraviolet Rays | 2008 |
The use of chitosan formulations in cancer therapy.
Topics: Apoptosis; Chitosan; Drug Carriers; Humans; Neoplasms | 2008 |
2 trial(s) available for chitosan and Neoplasms
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer.
Topics: Administration, Intranasal; Adult; Aged; Analgesics, Opioid; Chitin; Chitosan; Drug Therapy, Combination; Female; Hemostatics; Humans; Male; Middle Aged; Morphine; Neoplasms; Pain; Pilot Projects | 2002 |
344 other study(ies) available for chitosan and Neoplasms
| Article | Year |
|---|---|
N-trimethyl chitosan coated nano-complexes enhance the oral bioavailability and chemotherapeutic effects of gemcitabine.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Deoxycytidine; Drug Carriers; Drug Liberation; Gemcitabine; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Vitamin E | 2021 |
Thiol-Responsive Gold Nanodot Swarm with Glycol Chitosan for Photothermal Cancer Therapy.
Topics: Animals; Chitosan; Gold; Humans; Laser Therapy; Male; Metal Nanoparticles; Mice, Inbred BALB C; Neoplasms; Particle Size; Photothermal Therapy; Sulfhydryl Compounds; Temperature; Xenograft Model Antitumor Assays | 2021 |
Effect of targeting ligand designation of self-assembly chitosan-poloxamer nanogels loaded Paclitacel on inhibiting MCF-7 cancer cell growth.
Topics: Cell Line, Tumor; Chitosan; Drug Carriers; Folic Acid; Humans; Ligands; MCF-7 Cells; Nanogels; Nanoparticles; Neoplasms; Paclitaxel; Poloxamer | 2022 |
Synthesis, characterization, and anti-tumor properties of O-benzoylselenoglycolic chitosan.
Topics: Antineoplastic Agents; Apoptosis; Chitosan; Hep G2 Cells; Humans; Neoplasms; Selenium | 2021 |
Preparation and Characterization of Docetaxel-PLGA Nanoparticles Coated with Folic Acid-chitosan Conjugate for Cancer Treatment.
Topics: Chitosan; Docetaxel; Folic Acid; Humans; Lactic Acid; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2022 |
Sensitive ratiometric fluorescence probe based on chitosan carbon dots and calcein for Alkaline phosphatase detection and bioimaging in cancer cells.
Topics: Alkaline Phosphatase; Carbon; Chitosan; Fluoresceins; Fluorescent Dyes; Humans; Neoplasms; Quantum Dots | 2021 |
Injectable and Biodegradable Chitosan Hydrogel-Based Drug Depot Contributes to Synergistic Treatment of Tumors.
Topics: Chitosan; Humans; Hydrogels; Hyperthermia, Induced; Injections; Neoplasms | 2021 |
Bioinspired synthesis of protein/polysaccharide-decorated folate as a nanocarrier of curcumin to potentiate cancer therapy.
Topics: Alginates; Animals; Chitosan; Curcumin; Folic Acid; Mice; Nanoparticles; Neoplasms | 2022 |
Mesoporous silica@chitosan@gold nanoparticles as "on/off" optical biosensor and pH-sensitive theranostic platform against cancer.
Topics: Biosensing Techniques; Chitosan; Drug Carriers; Drug Delivery Systems; Gold; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Nanoparticles; Neoplasms; Precision Medicine; Silicon Dioxide | 2022 |
Chitosan derivatives functionalized dual ROS-responsive nanocarriers to enhance synergistic oxidation-chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Liberation; Female; Humans; Mice, Inbred BALB C; Mitochondria; Nanoparticles; Naphthoquinones; Neoplasms; Organophosphorus Compounds; Oxidation-Reduction; Oxidative Stress; Prodrugs; Reactive Oxygen Species; Silicon Dioxide; Tumor Burden | 2022 |
The Fluorescent Effect of Withania Somnifera Chitosan Nanocomposite as an Effective Contrast Agent for Cancer Theragnostic: Experimental Study in Vitro.
Topics: Caco-2 Cells; Chitosan; Contrast Media; Humans; Nanocomposites; Neoplasms; Plant Extracts; Withania | 2022 |
Co-delivery of doxorubicin and CRISPR/Cas9 or RNAi-expressing plasmid by chitosan-based nanoparticle for cancer therapy.
Topics: Cell Line, Tumor; Chitosan; CRISPR-Cas Systems; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Frontotemporal Dementia; Humans; Nanoparticles; Neoplasms; Plasmids; RNA Interference; Survivin | 2022 |
In situ injectable nano-complexed hydrogel based on chitosan/dextran for combining tumor therapy via hypoxia alleviation and TAMs polarity regulation.
Topics: Chitosan; Dextrans; Humans; Hydrogels; Hypoxia; Neoplasms; Tumor Microenvironment; Tumor-Associated Macrophages | 2022 |
Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting.
Topics: Animals; Cancer Vaccines; Cell Line, Tumor; Chitosan; Dendritic Cells; Immunotherapy; Mice; Neoplasms | 2022 |
Dynamic carboxymethyl chitosan-based nano-prodrugs precisely mediate robust synergistic chemotherapy.
Topics: Antineoplastic Agents; Chitosan; Glutathione; Humans; Nanoparticles; Neoplasms; Prodrugs; Water | 2022 |
Nanofabrication of PLGA-PEG-chitosan-folic acid systems for delivery of colchicine to HT-29 cancer cells.
Topics: Antioxidants; Chitosan; Colchicine; Drug Carriers; Folic Acid; Humans; Nanoparticles; Neoplasms; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer | 2023 |
Evaluation of thermosensitive chitosan hydrogel containing gefitinib loaded cellulose acetate butyrate nanoparticles in a subcutaneous breast cancer model.
Topics: Animals; Butyrates; Cellulose; Chitosan; Drug Carriers; Gefitinib; Hydrogels; Mice; Nanoparticles; Neoplasms; Particle Size | 2022 |
Graphene oxide quantum dot-chitosan nanotheranostic platform as a pH-responsive carrier for improving curcumin uptake internalization: In vitro & in silico study.
Topics: Chitosan; Curcumin; Graphite; Humans; Hydrogen-Ion Concentration; Molecular Docking Simulation; Neoplasms; Quantum Dots; Theranostic Nanomedicine | 2022 |
ROS-generating, pH-responsive and highly tunable reduced graphene oxide-embedded microbeads showing intrinsic anticancer properties and multi-drug co-delivery capacity for combination cancer therapy.
Topics: Alginates; Chitosan; Curcumin; Drug Carriers; Drug Liberation; Fluorouracil; Graphite; Humans; Hydrogen-Ion Concentration; Microspheres; Neoplasms; Reactive Oxygen Species | 2022 |
Evaluation of perfluoropropane (C
Topics: Chitosan; Contrast Media; Humans; Neoplasms; Sentinel Lymph Node; Ultrasonography | 2022 |
Effect of nanovesicular surface-functionalization via chitosan and/or PEGylation on cytotoxicity of tamoxifen in induced-breast cancer model.
Topics: Animals; Annexins; Apoptosis; bcl-2-Associated X Protein; Caspase 9; Chitosan; Liposomes; Necrosis; Neoplasms; Polyethylene Glycols; Rats; Tamoxifen | 2022 |
Chitosan/Gamma-Alumina/Fe
Topics: Aluminum Oxide; Chitosan; Drug Carriers; Fluorouracil; Humans; Nanoparticles; Neoplasms; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2022 |
Sequentially sustained release of anticarcinogens for postsurgical chemoimmunotherapy.
Topics: Animals; Anticarcinogenic Agents; Antigens, Neoplasm; Chitosan; Delayed-Action Preparations; Immunotherapy; Mice; Neoplasm Recurrence, Local; Neoplasms; Postoperative Care | 2022 |
Targeted chitosan nanoparticles embedded into graphene oxide functionalized with caffeic acid as a potential drug delivery system: New insight into cancer therapy.
Topics: Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Graphite; Hydrogen-Ion Concentration; Nanoparticles; Neoplasms; Spectroscopy, Fourier Transform Infrared | 2022 |
A novel approach of encapsulating curcumin and succinylated derivative in mannosylated-chitosan nanoparticles.
Topics: Chitosan; Curcumin; Drug Carriers; Humans; Mannose; Nanoparticles; Neoplasms; Particle Size; Succinic Anhydrides | 2022 |
Therapeutic Potential of Genistein: Preclinical Studies, Clinical Evidence, and Nanotechnology Application.
Topics: Animals; Chitosan; Drug Delivery Systems; Genistein; Humans; Nanotechnology; Neoplasms | 2023 |
Multifunctional chitosan ferrogels for targeted cancer therapy by on-demand magnetically triggered drug delivery and hyperthermia.
Topics: Chitosan; Doxorubicin; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Neoplasms; Tumor Microenvironment | 2022 |
Gold Nanoparticle-Incorporated Chitosan Nanogels as a Theranostic Nanoplatform for CT Imaging and Tumour Chemotherapy.
Topics: Chitosan; Cysteine; Doxorubicin; Drug Carriers; Gold; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Muramidase; Nanogels; Nanoparticles; Neoplasms; Polymers; Precision Medicine; Theranostic Nanomedicine; Tomography, X-Ray Computed | 2022 |
A glutathione-sensitive drug delivery system based on carboxymethyl chitosan co-deliver Rose Bengal and oxymatrine for combined cancer treatment.
Topics: Chitosan; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms; Phosphatidylinositol 3-Kinases; Rose Bengal | 2023 |
Metformin modified chitosan as a multi-functional adjuvant to enhance cisplatin-based tumor chemotherapy efficacy.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; B7-H1 Antigen; Cell Line, Tumor; Chitosan; Cisplatin; Drug Resistance, Neoplasm; Humans; Metformin; Neoplasms | 2023 |
Isolongifolene-loaded chitosan nanoparticles synthesis and characterization for cancer treatment.
Topics: Chitosan; Drug Carriers; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Neoplasms; Particle Size; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2022 |
Cinnamon cassia oil chitosan nanoparticles: Physicochemical properties and anti-breast cancer activity.
Topics: Animals; Cassia; Chitosan; Cinnamomum zeylanicum; Mice; Nanoparticles; Neoplasms; Oils, Volatile; Particle Size | 2023 |
The diminution and modulation role of water-soluble gallic acid-carboxymethyl chitosan conjugates against the induced nephrotoxicity with cisplatin.
Topics: Animals; Chitosan; Cisplatin; Gallic Acid; Neoplasms; Rats; Water | 2022 |
Layer-by-layer development of chitosan/alginate-based platelet-mimicking nanocapsules for augmenting doxorubicin cytotoxicity against breast cancer.
Topics: Alginates; Animals; Chitosan; Doxorubicin; Female; Mastectomy; Mice; Nanocapsules; Nanoparticles; Neoplasms | 2023 |
A pH-responsive chiral mesoporous silica nanoparticles for delivery of doxorubicin in tumor-targeted therapy.
Topics: Chitosan; Doxorubicin; Humans; Hydrogen-Ion Concentration; Nanoparticles; Neoplasms; Silicon Dioxide; Tumor Microenvironment | 2023 |
Tumor micro-environment sensitive release of doxorubicin through chitosan based polymeric nanoparticles: An in-vitro study.
Topics: Chitosan; Doxorubicin; Drug Carriers; Drug Liberation; Humans; Nanoparticles; Neoplasms; Particle Size; Polymers; Spectroscopy, Fourier Transform Infrared; Tumor Microenvironment | 2023 |
Development of chitosan/halloysite/graphitic‑carbon nitride nanovehicle for targeted delivery of quercetin to enhance its limitation in cancer therapy: An in vitro cytotoxicity against MCF-7 cells.
Topics: Antineoplastic Agents; Chitosan; Clay; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Neoplasms; Quercetin | 2023 |
Co-delivery of immunochemotherapeutic by classified targeting based on chitosan and cyclodextrin derivatives.
Topics: Animals; Apoptosis; Chitosan; Doxorubicin; Mice; Nanoparticles; Neoplasms | 2023 |
Piezo-Activated Atomic-Thin Molybdenum Disulfide/MXene Nanoenzyme for Integrated and Efficient Tumor Therapy via Ultrasound-Triggered Schottky Electric Field.
Topics: Chitosan; Humans; Molybdenum; Neoplasms; Tumor Microenvironment | 2023 |
Tumor Targeting and pH-Sensitive Inclusion Complex Based on HP-β-CD as a Potential Carrier for Paclitaxel: Fabrication, Molecular Docking, and Characterization.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chitosan; Drug Carriers; Excipients; Folic Acid; Humans; Hydrogen-Ion Concentration; Molecular Docking Simulation; Neoplasms; Paclitaxel | 2023 |
Fluorinated carboxymethyl chitosan-based nano-prodrugs for precisely synergistic chemotherapy.
Topics: Antineoplastic Agents; Chitosan; Drug Carriers; Humans; Nanoparticles; Neoplasms; Prodrugs | 2023 |
Onion-like doxorubicin-carrying polymeric nanomicelles with tumor acidity-sensitive dePEGylation to expose positively-charged chitosan shell for enhanced cancer chemotherapy.
Topics: Cell Line, Tumor; Chitosan; Doxorubicin; Humans; Hydrogen-Ion Concentration; Micelles; Nanoparticles; Neoplasms; Onions; Polyethylene Glycols; Polymers; Tumor Microenvironment | 2023 |
Clay nanosheets simultaneously intercalated and stabilized by PEGylated chitosan as drug delivery vehicles for cancer chemotherapy.
Topics: Chitosan; Clay; Doxorubicin; Drug Delivery Systems; Humans; Neoplasms; Polyethylene Glycols | 2023 |
Synthesis of biodegradable antimicrobial pH-sensitive silver nanocomposites reliant on chitosan and carrageenan derivatives for 5-fluorouracil drug delivery toward HCT116 cancer cells.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carrageenan; Chitosan; Fluorouracil; HCT116 Cells; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Nanocomposites; Neoplasms; Silver | 2023 |
Topics: Biotin; Chitosan; Curcumin; Drug Carriers; Gallium Radioisotopes; Nanocomposites; Nanoparticles; Neoplasms; Spectroscopy, Fourier Transform Infrared | 2023 |
Acid-Responsive Immune-Enhancing Chitosan Formulation Capable of Transforming from Particle Stabilization to Polymer Chain Stabilization.
Topics: Animals; Antigen-Presenting Cells; Antigens; Chitosan; Emulsions; Mice; Neoplasms; Polymers | 2023 |
In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity.
Topics: Animals; Cardiotoxicity; Chitosan; Drug Delivery Systems; Mice; Nanoparticles; Neoplasms | 2023 |
Injectable nano-composite hydrogels based on hyaluronic acid-chitosan derivatives for simultaneous photothermal-chemo therapy of cancer with anti-inflammatory capacity.
Topics: Anti-Inflammatory Agents; Chitosan; Doxorubicin; Humans; Hyaluronic Acid; Hydrogels; Inflammation; Nanogels; Nanoparticles; Neoplasms; Phototherapy; Photothermal Therapy | 2023 |
T cell-loaded injectable chitosan scaffold shows short-term efficacy in localised cancer immunotherapy in mice.
Topics: Animals; Chitosan; Disease Models, Animal; Humans; Hydrogels; Immunotherapy; Mice; Mice, Inbred C57BL; Neoplasms; T-Lymphocytes | 2023 |
Thermosensitive polymers-based injectable hydrogels: a quantitative validations design utilized for controlled delivery of gefitinib anticancer drug.
Topics: Animals; Antineoplastic Agents; Chitosan; Gefitinib; Hydrogels; Neoplasms; Poloxamer; Polymers; Rats; Temperature | 2023 |
In-vivo anticancer efficacy of self-targeted methotrexate-loaded polymeric nanoparticles in solid tumor-bearing rat.
Topics: Animals; Chitosan; Drug Carriers; Methotrexate; Nanoparticles; Neoplasms; Rats | 2023 |
Redox and pH dual sensitive carboxymethyl chitosan functionalized polydopamine nanoparticles loaded with doxorubicin for tumor chemo-photothermal therapy.
Topics: Chitosan; Doxorubicin; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Nanoparticles; Neoplasms; Oxidation-Reduction; Phototherapy; Photothermal Therapy; Tumor Microenvironment | 2023 |
Combination of a STING Agonist and Photothermal Therapy Using Chitosan Hydrogels for Cancer Immunotherapy.
Topics: Chitosan; Humans; Immunotherapy; Membrane Proteins; Neoplasms; Photothermal Therapy; Reactive Oxygen Species; Tumor Microenvironment | 2023 |
Lawsone encapsulated polylactic-co-glycolic acid nanoparticles modified with chitosan-folic acid successfully inhibited cell growth and triggered apoptosis in Panc-1 cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Chitosan; Drug Carriers; Folic Acid; Glycols; Lactic Acid; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2023 |
A ROS-response hyaluronic acid-coated/chitosan polymer prodrug for enhanced tumour targeting efficacy of SN38.
Topics: Animals; Camptothecin; Cell Line, Tumor; Chitosan; Hyaluronic Acid; Irinotecan; Mice; Neoplasms; Polymers; Prodrugs; Reactive Oxygen Species; Tumor Microenvironment | 2023 |
A novel thermoresponsive nano carrier matrix of hyaluronic acid, methotrexate and chitosan to target the cluster of differentiation 44 receptors in tumors.
Topics: Chitosan; Humans; Hyaluronic Acid; Methotrexate; Nanoparticles; Neoplasms | 2023 |
Magnetic chitosan oligomer-sulfonate-stearic acid triple combination as cisplatin carrier for site-specific targeted on MCF-7 cancer cells: Preparation, characterization and in vitro experiments.
Topics: Chitosan; Cisplatin; Humans; MCF-7 Cells; Neoplasms; Spectroscopy, Fourier Transform Infrared | 2023 |
Biocompatible polysaccharide fabricated graphene oxide nanoparticles: A versatile nanodrug carrier to deliver κ- carrageenan against cancer cells.
Topics: Antineoplastic Agents; Carrageenan; Chitosan; Drug Carriers; Drug Delivery Systems; Graphite; Humans; Hydrogen-Ion Concentration; Nanoparticles; Neoplasms | 2023 |
Multi-stimuli-responsive chitosan-functionalized magnetite/poly(ε-caprolactone) nanoparticles as theranostic platforms for combined tumor magnetic resonance imaging and chemotherapy.
Topics: Animals; Chitosan; Ferrosoferric Oxide; Gemcitabine; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Mice, SCID; Nanoparticles; Neoplasms; Precision Medicine | 2023 |
Chitosan Thermosensitive Hydrogel Based on DNA Damage Repair Inhibition and Mild Photothermal Therapy for Enhanced Antitumor Treatment.
Topics: Cell Line, Tumor; Chitosan; DNA Damage; Gold; Humans; Hydrogels; Metal Nanoparticles; Neoplasms; Photothermal Therapy | 2023 |
Chitosan-Biotin-Conjugated pH-Responsive Ru(II) Glucose Nanogel: A Dual Pathway of Targeting Cancer Cells and Self-Drug Delivery.
Topics: Animals; Biotin; Chitosan; Glucose; Humans; Hydrogen-Ion Concentration; Nanogels; Neoplasms; Zebrafish | 2023 |
Achieving enhanced sensitivity and accuracy in carcinoembryonic antigen (CEA) detection as an indicator of cancer monitoring using thionine/chitosan/graphene oxide nanocomposite-modified electrochemical immunosensor.
Topics: Biosensing Techniques; Carcinoembryonic Antigen; Chitosan; Electrochemical Techniques; Gold; Humans; Immunoassay; Limit of Detection; Metal Nanoparticles; Nanocomposites; Neoplasms | 2023 |
Morphological and fractal features of cancer cells anchored on composite layers based on magnesium-doped hydroxyapatite loaded in chitosan matrix.
Topics: Chitosan; Durapatite; Fractals; Humans; Magnesium; Neoplasms; Surface Properties | 2024 |
A drug-delivery depot for epigenetic modulation and enhanced cancer immunotherapy.
Topics: Animals; Chitosan; DNA; Drug Carriers; Epigenesis, Genetic; Immunotherapy; Methyltransferases; Mice; Nanoparticles; Neoplasms | 2023 |
Wearable Microneedle-Based Array Patches for Continuous Electrochemical Monitoring and Drug Delivery: Toward a Closed-Loop System for Methotrexate Treatment.
Topics: Chitosan; Humans; Methotrexate; Needles; Neoplasms; Wearable Electronic Devices | 2023 |
Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade.
Topics: Adenosine; Caffeine; Chitosan; Folic Acid; Humans; Immunotherapy; Methotrexate; Molecular Docking Simulation; Nanoparticles; Neoplasms; Receptor, Adenosine A2A; Tumor Microenvironment | 2023 |
In situ injectable thermoresponsive nanocomposite hydrogel based on hydroxypropyl chitosan for precise synergistic calcium-overload, photodynamic and photothermal tumor therapy.
Topics: Calcium; Cell Line, Tumor; Chitosan; Humans; Hydrogels; Hydrogen Peroxide; Indocyanine Green; Nanogels; Nanoparticles; Neoplasms; Photochemotherapy | 2024 |
Anti-EGFR antibody conjugated thiol chitosan-layered gold nanoshells for dual-modal imaging-guided cancer combination therapy.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chitosan; Combined Modality Therapy; Diagnostic Imaging; Drug Liberation; ErbB Receptors; Erythrocytes; Female; Gold; Humans; Mice, Inbred BALB C; Mice, Nude; Nanoshells; Neoplasms; Paclitaxel; Photoacoustic Techniques; Sulfhydryl Compounds; Theranostic Nanomedicine | 2019 |
A novel biocompatible core-shell magnetic nanocomposite based on cross-linked chitosan hydrogels for in vitro hyperthermia of cancer therapy.
Topics: Biocompatible Materials; Chitosan; Humans; Hydrogels; Hyperthermia, Induced; Magnetite Nanoparticles; Nanocomposites; Neoplasms; Phthalic Acids; Spectroscopy, Fourier Transform Infrared; Thiourea | 2019 |
Nuclear-targeted p53 and DOX co-delivery of chitosan derivatives for cancer therapy in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Nucleus; Cell Survival; Chitosan; Doxorubicin; Drug Delivery Systems; Gene Transfer Techniques; Hep G2 Cells; Humans; Mice, Nude; Neoplasms; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2019 |
Core-shell-corona chitosan-based micelles for tumor intracellular pH-triggered drug delivery: Improving performance by grafting polycation.
Topics: Chitosan; Delayed-Action Preparations; Doxorubicin; Hep G2 Cells; Humans; Micelles; Neoplasms; Polyethylene Glycols; Polymethacrylic Acids; Protein Corona | 2019 |
New approaches to tumor therapy with siRNA-decorated and chitosan-modified PLGA nanoparticles.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cancer Pain; Cell Line, Tumor; Cell Survival; Chitosan; Cyclooxygenase Inhibitors; Drug Carriers; Flurbiprofen; Folic Acid; Humans; Mice; Nanoparticles; Neoplasms; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; RNA, Small Interfering; STAT3 Transcription Factor | 2019 |
Doxorubicin - chitosan - hydroxyapatite composite coatings on titanium alloy for localized cancer therapy.
Topics: Alloys; Cell Line, Tumor; Chitosan; Coated Materials, Biocompatible; Doxorubicin; Durapatite; Electrochemical Techniques; Humans; Microscopy, Electron, Scanning; Neoplasms; Porosity; Spectroscopy, Fourier Transform Infrared; Surface Properties; Titanium; X-Ray Diffraction | 2019 |
Bi-faceted delivery of phytochemicals through chitosan nanoparticles impregnated nanofibers for cancer therapeutics.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Chitosan; Coumaric Acids; Drug Delivery Systems; Drug Liberation; Humans; Nanofibers; Nanoparticles; Neoplasms; Phytochemicals; Polyesters; Reactive Oxygen Species; Resveratrol | 2020 |
A versatile endosome acidity-induced sheddable gene delivery system: increased tumor targeting and enhanced transfection efficiency.
Topics: Animals; Cell Death; Cell Line, Tumor; Chitosan; DNA; Endocytosis; Endosomes; Female; Folic Acid; Genetic Therapy; Green Fluorescent Proteins; Humans; Hydrogen-Ion Concentration; Mice, Inbred BALB C; Neoplasms; Nuclear Localization Signals; Particle Size; Plasmids; Polyethylene Glycols; Polyethyleneimine; Static Electricity; Transfection | 2019 |
Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Chitosan; Doxorubicin; Drug Delivery Systems; Drug Liberation; Graphite; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Mice; Nanoparticles; Neoplasms; Oxidation-Reduction; Spectroscopy, Fourier Transform Infrared; Temperature | 2019 |
Folic acid-conjugated chitosan-functionalized graphene oxide for highly efficient photoacoustic imaging-guided tumor-targeted photothermal therapy.
Topics: Animals; Cell Line, Tumor; Chitosan; Female; Folic Acid; Graphite; Humans; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Neoplasms; Photoacoustic Techniques; Photothermal Therapy; Theranostic Nanomedicine | 2020 |
Evaluation of intestinal permeation enhancement with carboxymethyl chitosan-rhein polymeric micelles for oral delivery of paclitaxel.
Topics: Administration, Oral; Animals; Anthraquinones; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Caco-2 Cells; Chitosan; Disease Models, Animal; Drug Carriers; Drug Compounding; Humans; Intestinal Mucosa; Male; Mice; Micelles; Neoplasms; Paclitaxel; Permeability; Rats; Tissue Distribution; Verapamil | 2020 |
Preparation of sulfatide mimicking oleic acid sulfated chitosan as a potential inhibitor for metastasis.
Topics: Antineoplastic Agents; Chitosan; HeLa Cells; Humans; Neoplasm Metastasis; Neoplasms; Oleic Acid; Sulfoglycosphingolipids | 2020 |
New synthetic chitosan hybrids bearing some heterocyclic moieties with potential activity as anticancer and apoptosis inducers.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Cycle Checkpoints; Chitosan; HCT116 Cells; Hep G2 Cells; Heterocyclic Compounds; Humans; MCF-7 Cells; Neoplasms; Proto-Oncogene Proteins c-bcl-2 | 2020 |
Augmented anticancer activity of curcumin loaded fungal chitosan nanoparticles.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Chitosan; Curcumin; Drug Carriers; HCT116 Cells; Humans; Mucorales; Nanoparticles; Neoplasms | 2020 |
A microfluidic platform culturing two cell lines paralleled under in-vivo like fluidic microenvironment for testing the tumor targeting of nanoparticles.
Topics: A549 Cells; Animals; Apoptosis; Cell Proliferation; Chitosan; Cholesterol; Folic Acid; HeLa Cells; Humans; Mice; Mice, Nude; Microfluidics; Nanoparticles; Neoplasms; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2020 |
Selective uptake of chitosan polymeric micelles by circulating monocytes for enhanced tumor targeting.
Topics: Animals; Antineoplastic Agents; Chitosan; Doxorubicin; Drug Carriers; Drug Liberation; Endocytosis; Exocytosis; Female; Mice; Mice, Inbred BALB C; Micelles; Monocytes; Neoplasms; RAW 264.7 Cells | 2020 |
Biocompatible chitosan-carbon nanocage hybrids for sustained drug release and highly efficient laser and microwave co-irradiation induced cancer therapy.
Topics: Animals; Biocompatible Materials; Carbon; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Chitosan; Delayed-Action Preparations; Drug Liberation; Fluorouracil; Lasers; Mice, Inbred BALB C; Mice, Nude; Microwaves; Nanoparticles; Neoplasms; Photothermal Therapy; Temperature | 2020 |
Chitosan capped pH-responsive hollow mesoporous silica nanoparticles for targeted chemo-photo combination therapy.
Topics: Antineoplastic Agents; Chitosan; Chlorophyll; Combined Modality Therapy; Doxorubicin; Drug Delivery Systems; Drug Liberation; Drug Resistance, Multiple; Endocytosis; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Neoplasms; Silicon Dioxide | 2020 |
Immunostimulatory effect of chitosan conjugated green copper oxide nanoparticles in tumor immunotherapy.
Topics: Adjuvants, Immunologic; Animals; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cells, Cultured; Chitosan; Copper; Female; HeLa Cells; Humans; Immunotherapy; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms | 2020 |
An Automatable Hydrogel Culture Platform for Evaluating Efficacy of Antibody-Based Therapeutics in Overcoming Chemoresistance.
Topics: A549 Cells; Aldehyde Dehydrogenase, Mitochondrial; Alginates; Antineoplastic Agents, Immunological; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Chitosan; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Heme Oxygenase-1; High-Throughput Screening Assays; Humans; Hydrogels; Male; Neoplasms; Paclitaxel; Proteomics | 2020 |
Formulation of a pH-sensitive cancer cell-targeted gene delivery system based on folate-chitosan conjugated nanoparticles.
Topics: Chitosan; DNA; Folic Acid; Gene Transfer Techniques; Humans; Hydrogen-Ion Concentration; Nanoparticles; Neoplasms | 2021 |
Drug-Loaded Photosensitizer-Chitosan Nanoparticles for Combinatorial Chemo- and Photodynamic-Therapy of Cancer.
Topics: Animals; Chitosan; Drug Carriers; Mice; Nanoparticles; Neoplasms; Pharmaceutical Preparations; Photochemotherapy; Photosensitizing Agents; Tissue Distribution | 2020 |
Novel Chitosan Derivatives with Reversible Cationization and Hydrophobicization for Tumor Cytoplasm-Specific Burst Co-delivery of siRNA and Chemotherapeutics.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Cations; Chitosan; Cytoplasm; Drug Carriers; Female; Glutathione; Humans; Hyaluronic Acid; Mice; Mice, Nude; Micelles; Neoplasms; Paclitaxel; Particle Size; Polyethyleneimine; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2020 |
Ultrasound-responsive highly biocompatible nanodroplets loaded with doxorubicin for tumor imaging and treatment
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Ultrasonography | 2020 |
Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progression.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Movement; Chick Embryo; Chitosan; Chorioallantoic Membrane; Dextrans; Drug Carriers; Drug Compounding; Drug Liberation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Mice; Nanoparticles; Neoplasms; Oligopeptides; RNA, Small Interfering; STAT3 Transcription Factor | 2020 |
Effect of electrical discharge plasma on cytotoxicity against cancer cells of N,O-carboxymethyl chitosan-stabilized gold nanoparticles.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Chitosan; Electrochemistry; Gold; Humans; Metal Nanoparticles; Neoplasms | 2020 |
Design and Characterization of a Cancer-Targeted Drug Co-Delivery System Composed of Liposomes and Selenium Nanoparticles.
Topics: Chitosan; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Folic Acid; HeLa Cells; Humans; Liposomes; Nanoparticles; Neoplasms; Renal Dialysis; Selenium; Spectroscopy, Fourier Transform Infrared | 2020 |
Optically controlled hybrid metamaterial of plasmonic spiky gold inbuilt graphene sheets for bimodal imaging guided multimodal therapy.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Doxorubicin; Folic Acid; Gold; Graphite; Humans; Mice; Nanostructures; Neoplasms; Photochemotherapy; Photosensitizing Agents; Phototherapy; Protoporphyrins; Spectrum Analysis, Raman | 2020 |
Tumor-draining lymph node targeting chitosan micelles as antigen-capturing adjuvants for personalized immunotherapy.
Topics: Adjuvants, Immunologic; Animals; Cell Line, Tumor; Chitosan; Dendritic Cells; Immunotherapy; Lymph Nodes; Mice; Mice, Inbred C57BL; Micelles; Neoplasms | 2020 |
ROS-Responsive Chitosan Coated Magnetic Iron Oxide Nanoparticles as Potential Vehicles for Targeted Drug Delivery in Cancer Therapy.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Ferric Compounds; Fluorouracil; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Magnetite Nanoparticles; Neoplasms; Oleic Acid; Particle Size; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared; Temperature; X-Ray Diffraction | 2020 |
Reactive oxygen species-sensitive nanophotosensitizers of aminophenyl boronic acid pinacol ester conjugated chitosan-g-methoxy poly(ethylene glycol) copolymer for photodynamic treatment of cancer.
Topics: Animals; Boronic Acids; Cell Line, Tumor; Cell Survival; Chitosan; Esters; Glycols; Humans; Hydrogen Peroxide; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Nanomedicine; Nanoparticles; Nanotechnology; Neoplasm Transplantation; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Polymers; Reactive Oxygen Species; Water | 2020 |
Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression.
Topics: 5'-Nucleotidase; Animals; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Chitosan; Disease Progression; Drug Liberation; Female; Gene Expression Regulation, Neoplastic; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Iron Oxide Nanoparticles; Mice, Inbred BALB C; Neoplasms; RNA, Small Interfering; tat Gene Products, Human Immunodeficiency Virus | 2020 |
Design and evaluation of the anticancer activity of paclitaxel-loaded anisotropic-poly(lactic-co-glycolic acid) nanoparticles with PEGylated chitosan surface modifications.
Topics: Antineoplastic Agents; Chitosan; Drug Design; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Nanoparticles; Neoplasms; Paclitaxel; Polyethylene Glycols; Polylactic Acid-Polyglycolic Acid Copolymer | 2020 |
Injectable corilagin/low molecular weight chitosan/PLGA-PEG-PLGA thermosensitive hydrogels for localized cancer therapy and promoting drug infiltration by modulation of tumor microenvironment.
Topics: Animals; Chitosan; Glucosides; Hydrogels; Hydrolyzable Tannins; Mice; Molecular Weight; Neoplasms; Polyesters; Polyethylene Glycols; Tumor Microenvironment | 2020 |
Fabrication of PNIPAM-chitosan/decatungstoeuropate/silica nanocomposite for thermo/pH dual-stimuli-responsive and luminescent drug delivery system.
Topics: Acrylic Resins; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Delivery Systems; Drug Liberation; Humans; Hydrogen-Ion Concentration; Luminescence; Nanocomposites; Neoplasms; Silicon Dioxide; Temperature; Tungsten | 2020 |
Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Galactose; Guanidines; Humans; Mice; Nanoparticles; Neoplasms; Receptors, CXCR4 | 2020 |
Fabrication of facile polymeric nanocomposites based on chitosan-gr-P2-aminothiophenol for biomedical applications.
Topics: Ammonium Sulfate; Cell Proliferation; Chitosan; Humans; Immune System; Metal Nanoparticles; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Neoplasms; Oxidation-Reduction; Polymers; Silver; Staphylococcus aureus | 2020 |
Drug Delivery Systems Based on Modified Polysaccharides: Synthesis and Characterization.
Topics: Antineoplastic Agents; Cellulose; Chitosan; Drug Carriers; Humans; Nanospheres; Neoplasms; Polymethyl Methacrylate | 2021 |
Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemical Phenomena; Chemistry Techniques, Synthetic; Chitosan; Dinoprostone; Disease Models, Animal; Humans; Hyaluronic Acid; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Iron Oxide Nanoparticles; Magnetite Nanoparticles; Mice; Neoplasms; Receptors, Prostaglandin E, EP4 Subtype; RNA, Small Interfering; Signal Transduction; Spectrum Analysis | 2021 |
Thermo-Triggered In Situ Chitosan-Based Gelation System for Repeated and Enhanced Sonodynamic Therapy Post a Single Injection.
Topics: Chitosan; Humans; Neoplasms; Reactive Oxygen Species; Ultrasonic Therapy; Ultrasonic Waves | 2021 |
Differences of the tumour cell glycocalyx affect binding of capsaicin-loaded chitosan nanocapsules.
Topics: Antipruritics; Capsaicin; Cell Line, Tumor; Cell Survival; Chitosan; Endothelial Cells; Glycocalyx; Heparitin Sulfate; Humans; Nanocapsules; Neoplasms; Organ Specificity; Protein Binding; Static Electricity; Theranostic Nanomedicine | 2020 |
Application of a novel thermo-sensitive injectable hydrogel in therapy in situ for drug accurate controlled release.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Female; Fluorouracil; Hydrogels; Materials Testing; Mice; Neoadjuvant Therapy; Neoplasms; Neoplasms, Experimental; Swine; Thermodynamics | 2020 |
Encapsulation of
Topics: A549 Cells; Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Chitosan; Drug Carriers; Humans; Nanoparticles; Neoplasms; Oils, Volatile; Satureja | 2021 |
Tumor microenvironment-responsive, high internal phase Pickering emulsions stabilized by lignin/chitosan oligosaccharide particles for synergistic cancer therapy.
Topics: Chitosan; Emulsions; Lignin; Nanoparticles; Neoplasms; Oligosaccharides; Particle Size; Tumor Microenvironment | 2021 |
Galactosylated Chitosan Modified Magnetic Mesoporous Silica Nanoparticles Loaded with Nedaplatin for the Targeted Chemo-Photothermal Synergistic Therapy of Cancer.
Topics: Cell Line, Tumor; Chitosan; Doxorubicin; Drug Delivery Systems; Drug Liberation; Magnetic Phenomena; Nanoparticles; Neoplasms; Organoplatinum Compounds; Phototherapy; Porosity; Silicon Dioxide | 2021 |
Chitosan nano-vehicles as biocompatible delivering tools for a new Ag(I)curcuminoid-Gboxin analog complex in cancer and inflammation therapy.
Topics: A549 Cells; Antineoplastic Agents; Caspase 3; Cell Proliferation; Cell Survival; Chitosan; Cytokines; Diarylheptanoids; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; MCF-7 Cells; Nanoparticles; Neoplasms; Silver; Up-Regulation | 2020 |
Topics: Antineoplastic Agents; Chitosan; Curcumin; Drug Carriers; Durapatite; Nanoparticles; Neoplasms; Spectroscopy, Fourier Transform Infrared | 2021 |
A novel biodegradable injectable chitosan hydrogel for overcoming postoperative trauma and combating multiple tumors.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; B7-H1 Antigen; Chitosan; Copper; Hemostatics; Humans; Hydrogels; Injections; Mice; Nanocomposites; Nanoparticles; Neoplasm Recurrence, Local; Neoplasms; Phosphorus; Reactive Oxygen Species; Surgical Wound Infection; Temperature | 2021 |
Protein corona precoating on redox-responsive chitosan-based nano-carriers for improving the therapeutic effect of nucleic acid drugs.
Topics: Animals; Chitosan; Drug Carriers; Drug Delivery Systems; Gene Silencing; Genetic Therapy; Humans; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Nucleic Acids; Oxidation-Reduction; Particle Size; Protein Corona; RNA, Small Interfering; Serum Albumin, Bovine; Vascular Endothelial Growth Factor A | 2021 |
Targeted delivery system using silica nanoparticles coated with chitosan and AS1411 for combination therapy of doxorubicin and antimiR-21.
Topics: Animals; Antagomirs; Antineoplastic Agents; Aptamers, Nucleotide; Cell Line, Tumor; Chitosan; CHO Cells; Cricetulus; Doxorubicin; Drug Carriers; Drug Liberation; Humans; Immobilized Nucleic Acids; Mice; MicroRNAs; Nanoparticles; Neoplasms; Oligodeoxyribonucleotides; Silicon Dioxide | 2021 |
Self-assembled chitosan polymer intercalating peptide functionalized gold nanoparticles as nanoprobe for efficient imaging of urokinase plasminogen activator receptor in cancer diagnostics.
Topics: Cell Line, Tumor; Chitosan; Gold; Humans; Immobilized Proteins; Metal Nanoparticles; Microscopy, Fluorescence; Molecular Docking Simulation; Neoplasms; Peptides; Protein Binding; Receptors, Urokinase Plasminogen Activator | 2021 |
Engineering of stealth (maghemite/PLGA)/chitosan (core/shell)/shell nanocomposites with potential applications for combined MRI and hyperthermia against cancer.
Topics: Cell Line, Tumor; Cell Survival; Chitosan; Engineering; Humans; Hyperthermia, Induced; Magnetite Nanoparticles; Nanocomposites; Neoplasms; Polylactic Acid-Polyglycolic Acid Copolymer | 2021 |
A multiple environment-sensitive prodrug nanomicelle strategy based on chitosan graftomer for enhanced tumor therapy of gambogic acid.
Topics: Acrylic Resins; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Carriers; Drug Liberation; Folic Acid; Humans; Hydrogen-Ion Concentration; Male; Mice; Micelles; Neoplasms; Prodrugs; Temperature; Xanthones | 2021 |
Chitosan, Polyethylene Glycol and Polyvinyl Alcohol Modified MgFe
Topics: Antibiotics, Antineoplastic; Caco-2 Cells; Chitosan; Doxorubicin; Drug Carriers; Ferric Compounds; HEK293 Cells; Humans; Magnetite Nanoparticles; Neoplasms; Polyethylene Glycols; Polyvinyl Alcohol | 2021 |
A pH-Sensitive Polymeric Micellar System Based on Chitosan Derivative for Efficient Delivery of Paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Cell Line; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Drug Liberation; Humans; MCF-7 Cells; Micelles; Neoplasms; Paclitaxel; Particle Size; Polymers | 2021 |
In vitro/vivo antitumor study of modified-chitosan/carboxymethyl chitosan "boosted" charge-reversal nanoformulation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carbohydrate Sequence; Chitosan; Dendrimers; Doxorubicin; Drug Carriers; Drug Liberation; Endocytosis; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Lysosomes; Male; Maleic Anhydrides; Mice, Inbred BALB C; Necrosis; Neoplasms; Polyamines; Xenograft Model Antitumor Assays | 2021 |
AIE-active polymeric micelles based on modified chitosan for bioimaging-guided targeted delivery and controlled release of paclitaxel.
Topics: Animals; Antineoplastic Agents; Carbohydrate Sequence; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Liberation; Female; Fluorescent Dyes; Humans; Mice; Micelles; Neoplasms; Paclitaxel | 2021 |
Fluorescence/photoacoustic imaging-guided nanomaterials for highly efficient cancer theragnostic agent.
Topics: Animals; Cell Line, Tumor; Chitosan; Fluorescence; Humans; Nanocomposites; Neoplasms; Optical Imaging; Photoacoustic Techniques; Phototherapy; Polymers; Pyrroles; Theranostic Nanomedicine | 2021 |
Enhanced antitumor efficacy of glutathione-responsive chitosan based nanoparticles through co-delivery of chemotherapeutics, genes, and immune agents.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Glutathione; Humans; Interleukin-2; Mice; Nanoparticles; Neoplasms; Paclitaxel; RNA, Small Interfering; Survivin | 2021 |
Marine-derived polymeric nanostructures for cancer treatment.
Topics: Alginates; Chitosan; Drug Delivery Systems; Nanoparticles; Nanostructures; Neoplasms; Particle Size; Polymers; Polysaccharides | 2021 |
Dual-Crosslinked Dynamic Hydrogel Incorporating {Mo
Topics: Animals; Cell Line; Cell Survival; Chitosan; Doxorubicin; Drug Carriers; Humans; Hydrogels; Hydrogen-Ion Concentration; Infrared Rays; Mice, Inbred C57BL; Neoplasms; Photothermal Therapy; Polyethylene Glycols; Transplantation, Heterologous | 2021 |
Chemotherapeutic and chemopreventive potentials of ρ-coumaric acid - Squid chitosan nanogel loaded with Syzygium aromaticum essential oil.
Topics: Animals; Antioxidants; Bacterial Infections; Cell Line, Tumor; Chitosan; Coumaric Acids; Decapodiformes; Humans; Microbial Sensitivity Tests; Nanogels; Neoplasms; Oils, Volatile; Oxidative Stress; Syzygium | 2021 |
Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites.
Topics: Alginates; Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Chlorophyllides; Delayed-Action Preparations; Doxorubicin; Drug Delivery Systems; Female; Genetic Therapy; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Mice, Inbred BALB C; Nanocomposites; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Silicon Dioxide; Theranostic Nanomedicine | 2017 |
Rolling circle transcription-based polymeric siRNA nanoparticles for tumor-targeted delivery.
Topics: Animals; Cell Line, Tumor; Chitosan; DNA, Circular; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; RNA, Small Interfering; Transcription, Genetic; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
Plasma membrane activatable polymeric nanotheranostics with self-enhanced light-triggered photosensitizer cellular influx for photodynamic cancer therapy.
Topics: A549 Cells; Animals; Cell Membrane; Chitosan; Erythrocytes; Female; Hemolysis; Humans; Light; Mice, Nude; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Protoporphyrins | 2017 |
Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
Topics: A549 Cells; Animals; Chitosan; Doxorubicin; Drug Delivery Systems; Humans; Indomethacin; Male; Nanoparticles; Neoplasms; Oligosaccharides; Rats; Rats, Sprague-Dawley | 2017 |
Acid-degradable carboxymethyl chitosan nanogels via an ortho ester linkage mediated improved penetration and growth inhibition of 3-D tumor spheroids in vitro.
Topics: Chitosan; Doxorubicin; Humans; Nanogels; Neoplasms; Polyethylene Glycols; Polyethyleneimine | 2017 |
Targeting integrin-rich tumors with temoporfin-loaded vitamin-E-succinate-grafted chitosan oligosaccharide/d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles to enhance photodynamic therapy efficiency.
Topics: Animals; Chitosan; Integrins; Mesoporphyrins; Mice; Mice, Nude; Nanoparticles; Neoplasms; Photochemotherapy; Polyethylene Glycols; Succinates; Vitamin E | 2017 |
Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study.
Topics: Antibiotics, Antineoplastic; Bromelains; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chitosan; Disaccharides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Liver Neoplasms; Nanoparticles; Neoplasms | 2017 |
Synthesis of folate‑chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells.
Topics: A549 Cells; Chitosan; Drug Liberation; Endocytosis; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Neoplasms; Proton Magnetic Resonance Spectroscopy; Pyrazines; Spectrophotometry, Infrared; Time Factors | 2017 |
Folate and Heptamethine Cyanine Modified Chitosan-Based Nanotheranostics for Tumor Targeted Near-Infrared Fluorescence Imaging and Photodynamic Therapy.
Topics: Carbocyanines; Chitosan; Drug Delivery Systems; Fluorescence; Folic Acid; HeLa Cells; Hep G2 Cells; Humans; Infrared Rays; Nanoparticles; Neoplasms; Photochemotherapy; Theranostic Nanomedicine | 2017 |
Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response.
Topics: Animals; Cell Line, Tumor; Chitosan; Gadolinium; Glutathione; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice, Inbred BALB C; Mice, Nude; Nanospheres; Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Reactive Oxygen Species; Tumor Hypoxia; Tungsten Compounds | 2017 |
An innovative MWCNTs/DOX/TC nanosystem for chemo-photothermal combination therapy of cancer.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Combined Modality Therapy; Doxorubicin; Drug Delivery Systems; Drug Liberation; Hyperthermia, Induced; Male; Mice, Inbred BALB C; Mice, Nude; Nanotubes, Carbon; Neoplasms; Phototherapy | 2017 |
Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents, Phytogenic; Chitosan; Drug Carriers; Drug Delivery Systems; Gels; Humans; Immunotherapy; Interleukin-2; Mice, Inbred C57BL; Neoplasms; Paclitaxel; Rats, Sprague-Dawley; Tumor Microenvironment | 2017 |
Formation and characterization of polyelectrolyte complex synthesized by chitosan and carboxylic curdlan for 5-fluorouracil delivery.
Topics: beta-Glucans; Chitosan; Drug Carriers; Fluorouracil; HeLa Cells; Humans; Nanoparticles; Neoplasms; Polyelectrolytes | 2018 |
Simple nanophotosensitizer fabrication using water-soluble chitosan for photodynamic therapy in gastrointestinal cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chitosan; Chlorophyllides; Humans; Light; Male; Mice, Nude; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Solubility; Tumor Burden; Water | 2017 |
Tumor cell culture on collagen-chitosan scaffolds as three-dimensional tumor model: A suitable model for tumor studies.
Topics: Animals; Cell Culture Techniques; Chitosan; Collagen; Mice; Neoplasms; Tissue Scaffolds; Tumor Cells, Cultured | 2016 |
Effects of tumor microenvironments on targeted delivery of glycol chitosan nanoparticles.
Topics: Animals; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Extracellular Matrix; Female; Humans; Mice, Nude; Microvessels; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Tissue Distribution; Tumor Burden; Tumor Microenvironment | 2017 |
mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Cell Line, Tumor; Chitosan; Chloroquine; Drug Delivery Systems; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Nanoparticles; Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2017 |
Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
Topics: Animals; Cell Line, Tumor; Chitosan; Drug Carriers; Female; Humans; Lactic Acid; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Optical Imaging; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Whole Body Imaging | 2017 |
Mucoadhesive alginate pastes with embedded liposomes for local oral drug delivery.
Topics: Adhesives; Administration, Oral; Alginates; Chitosan; Drug Compounding; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Liposomes; Neoplasms; Polymers | 2018 |
Multimodal tumor-homing chitosan oligosaccharide-coated biocompatible palladium nanoparticles for photo-based imaging and therapy.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Chitosan; Humans; Lasers; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Multimodal Imaging; Neoplasms; Oligopeptides; Oligosaccharides; Palladium; Photochemotherapy; Tissue Distribution; Transplantation, Heterologous | 2018 |
Developing single-entity theranostic: drug-based fluorescent nanoclusters with augmented cytotoxicity.
Topics: Apoptosis; Cell Proliferation; Cell Survival; Chitosan; Drug Delivery Systems; Gold; HeLa Cells; Humans; Metal Nanoparticles; Methotrexate; Neoplasms; Theranostic Nanomedicine | 2018 |
pH and near-infrared active; chitosan-coated halloysite nanotubes loaded with curcumin-Au hybrid nanoparticles for cancer drug delivery.
Topics: Aluminum Silicates; Cell Line, Tumor; Cell Survival; Chitosan; Clay; Curcumin; Drug Delivery Systems; Drug Liberation; Gold; Humans; Hydrogen-Ion Concentration; Nanoparticles; Nanotubes; Neoplasms | 2018 |
CD44-Targeted Facile Enzymatic Activatable Chitosan Nanoparticles for Efficient Antitumor Therapy and Reversal of Multidrug Resistance.
Topics: alpha-Tocopherol; Animals; Chitosan; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Hyaluronan Receptors; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Proteins; Neoplasms; NIH 3T3 Cells; Paclitaxel; Xenograft Model Antitumor Assays | 2018 |
Development of Enteromorpha prolifera polysaccharide-based nanoparticles for delivery of curcumin to cancer cells.
Topics: Cell Line, Tumor; Chitosan; Curcumin; Drug Carriers; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms; Polysaccharides | 2018 |
One-step synthesis of gene carrier via gamma irradiation and its application in tumor gene therapy.
Topics: Animals; Chitosan; DNA; Drug Delivery Systems; Gamma Rays; Genetic Therapy; HCT116 Cells; Hemolysis; Humans; Methacrylates; Mice; Neoplasms; Plasmids; Proto-Oncogene Proteins c-bcl-2; Proton Magnetic Resonance Spectroscopy; Rats; Solubility; Transfection; Water | 2018 |
Human Adipose Derived Stem Cells and Osteoblasts Interaction with Fe-Cr-Nb-B Magnetic Nanoparticles.
Topics: Adipose Tissue; Chitosan; Drug Delivery Systems; Humans; Hyperthermia, Induced; Magnetics; Magnetite Nanoparticles; Nanoparticles; Neoplasms; Osteoblasts; Stem Cells | 2018 |
MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent.
Topics: Animals; Carbocyanines; Cell Line; Chitosan; Coloring Agents; Coumarins; Humans; Hyperthermia, Induced; Light; Mice, Inbred BALB C; Mice, Nude; Micelles; Nanoparticles; Neoplasms; Paclitaxel; Phototherapy; Spectroscopy, Near-Infrared; Theranostic Nanomedicine; Thiazoles; Tissue Distribution | 2018 |
Rapid two-dimensional ALSOFAST-HSQC experiment for metabolomics and fluxomics studies: application to a
Topics: Antioxidants; Carbon Isotopes; Chitosan; Glucose; Gold; HeLa Cells; Humans; Magnetic Resonance Spectroscopy; Metabolome; Metabolomics; Metal Nanoparticles; Neoplasms; Time Factors | 2018 |
Highly Biocompatible Chlorin e6-Loaded Chitosan Nanoparticles for Improved Photodynamic Cancer Therapy.
Topics: Chitosan; Chlorophyllides; Humans; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins | 2018 |
Effective deactivation of A549 tumor cells in vitro and in vivo by RGD-decorated chitosan-functionalized single-walled carbon nanotube loading docetaxel.
Topics: A549 Cells; Animals; Antineoplastic Agents; Cell Survival; Chitosan; Docetaxel; Drug Carriers; Drug Liberation; Female; Humans; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Nanotubes, Carbon; Neoplasms; Oligopeptides; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
Bromelain-immobilized and lactobionic acid-modified chitosan nanoparticles for enhanced drug penetration in tumor tissues.
Topics: Animals; Antineoplastic Agents; Bromelains; Cell Death; Cell Line, Tumor; Cell Proliferation; Chitosan; Disaccharides; Doxorubicin; Drug Delivery Systems; Enzymes, Immobilized; Gelatin; Humans; Male; Mice, Inbred ICR; Nanoparticles; Neoplasms; Proton Magnetic Resonance Spectroscopy; Tissue Distribution | 2018 |
Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Brain; Caco-2 Cells; Camptothecin; Chitosan; Drug Carriers; Humans; Intestinal Absorption; Irinotecan; Lactic Acid; Male; MCF-7 Cells; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar | 2018 |
Improving antiproliferative effect of the nevirapine on Hela cells by loading onto chitosan coated magnetic nanoparticles as a fully biocompatible nano drug carrier.
Topics: Antineoplastic Agents; Cell Proliferation; Chitosan; Coated Materials, Biocompatible; Drug Carriers; HeLa Cells; Humans; Magnetite Nanoparticles; Neoplasms; Nevirapine | 2018 |
Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells and Tumor.
Topics: Chitosan; Curcumin; Doxorubicin; Drug Delivery Systems; Drug Liberation; Emulsions; Humans; Hyaluronic Acid; Nanoparticles; Neoplasms; Neoplastic Stem Cells; Polyvinyl Alcohol | 2018 |
Folate-modified carboxymethyl-chitosan/polyethylenimine/bovine serum albumin based complexes for tumor site-specific drug delivery.
Topics: A549 Cells; Animals; Antineoplastic Agents; Cell Survival; Chitosan; Drug Delivery Systems; Drug Liberation; Folic Acid; Humans; Male; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Polyethyleneimine; Serum Albumin, Bovine; TNF-Related Apoptosis-Inducing Ligand; Tumor Burden; Xanthones | 2018 |
Fabrication of chitosan based nanocomposite with legumain sensitive properties using charge driven self-assembly strategy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Cornea; Cysteine Endopeptidases; Doxorubicin; Drug Delivery Systems; Drug Liberation; Epithelial Cells; HeLa Cells; Humans; Mice; Microscopy, Electron, Transmission; Nanocomposites; Nanoparticles; Neoplasms; Organic Chemicals; Particle Size; Peptides; Polymers; Prodrugs; Solvents | 2018 |
Chitosan based copolymer-drug conjugate and its protein targeted polyelectrolyte complex nanoparticles to enhance the efficiency and specificity of low potency anticancer agent.
Topics: Antineoplastic Agents; Chitosan; Curcumin; Drug Delivery Systems; Humans; MCF-7 Cells; Nanoparticles; Neoplasms; Polyelectrolytes; Polyesters; Receptors, Transferrin | 2018 |
Negative Surface Shielded Polymeric Micelles with Colloidal Stability for Intracellular Endosomal/Lysosomal Escape.
Topics: Animals; Antibiotics, Antineoplastic; Biphenyl Compounds; Chitosan; Colloids; Doxorubicin; Drug Carriers; Drug Liberation; Endosomes; Female; Humans; Lysosomes; MCF-7 Cells; Mice; Mice, Inbred BALB C; Micelles; Neoplasms; Protein Corona; Xenograft Model Antitumor Assays | 2018 |
Glutathione responsive chitosan-thiolated dextran conjugated miR-145 nanoparticles targeted with AS1411 aptamer for cancer treatment.
Topics: Aptamers, Nucleotide; Chitosan; Dextrans; Drug Delivery Systems; Glutathione; Humans; MCF-7 Cells; MicroRNAs; Nanoparticles; Neoplasms | 2018 |
Cytotoxicity against cancer cells of chitosan oligosaccharides prepared from chitosan powder degraded by electrical discharge plasma.
Topics: Antineoplastic Agents; Chitosan; Cytotoxins; Drug Screening Assays, Antitumor; HeLa Cells; Humans; MCF-7 Cells; Neoplasms; Oligosaccharides; Plasma Gases | 2018 |
One-pot fabrication of pH/reduction dual-stimuli responsive chitosan-based supramolecular nanogels for leakage-free tumor-specific DOX delivery with enhanced anti-cancer efficacy.
Topics: beta-Cyclodextrins; Chitosan; Doxorubicin; Drug Delivery Systems; Gels; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Nanostructures; Neoplasms | 2018 |
An Immunologically Modified Nanosystem Based on Noncovalent Binding Between Single-Walled Carbon Nanotubes and Glycated Chitosan.
Topics: Chitosan; Drug Delivery Systems; Humans; Molecular Dynamics Simulation; Nanotubes, Carbon; Neoplasms | 2018 |
Chitosan/alginate nanoparticles as a promising approach for oral delivery of curcumin diglutaric acid for cancer treatment.
Topics: Alginates; Antineoplastic Agents; Caco-2 Cells; Chitosan; Curcumin; Hep G2 Cells; Humans; Nanoparticles; Neoplasms; Prodrugs | 2018 |
Genipin crosslinked curcumin loaded chitosan/montmorillonite K-10 (MMT) nanoparticles for controlled drug delivery applications.
Topics: Antineoplastic Agents; Bentonite; Cell Survival; Chitosan; Cross-Linking Reagents; Curcumin; Delayed-Action Preparations; Drug Liberation; Hep G2 Cells; Humans; Iridoids; MCF-7 Cells; Neoplasms | 2018 |
Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing Antibodies.
Topics: Adenoviridae; Antibodies, Neutralizing; Chitosan; Drug Carriers; Humans; Immunity, Cellular; Ligands; Nanoparticles; Neoplasms; Oncolytic Virotherapy; Oncolytic Viruses; Polyglutamic Acid; Polymers | 2018 |
Hexa-functional tumour-seeking nano voyagers and annihilators for synergistic cancer theranostic applications.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; NIH 3T3 Cells; Paclitaxel; Theranostic Nanomedicine; Transplantation, Heterologous | 2018 |
Stearic Acid-Grafted Chitooligosaccharide Nanomicelle System with Biocleavable Gadolinium Chelates as a Multifunctional Agent for Tumor Imaging and Drug Delivery.
Topics: Animals; Chelating Agents; Chitin; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Mice, Inbred ICR; Micelles; Nanoparticles; Neoplasms; Oligosaccharides; Stearic Acids | 2018 |
A smart tumor microenvironment responsive nanoplatform based on upconversion nanoparticles for efficient multimodal imaging guided therapy.
Topics: Animals; Biocompatible Materials; Cell Survival; Chitosan; Doxorubicin; Drug Carriers; Female; Folic Acid; HeLa Cells; Hemolysis; Humans; Infrared Rays; Mice; Microscopy, Confocal; Nanoparticles; Neoplasms; Porosity; Silicon Dioxide; Tomography, X-Ray Computed; Tungsten Compounds | 2019 |
Preparation and evaluation of carboxymethyl chitosan-rhein polymeric micelles with synergistic antitumor effect for oral delivery of paclitaxel.
Topics: Administration, Oral; Animals; Anthraquinones; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Liberation; Drug Synergism; Humans; Male; Mice, Inbred ICR; Micelles; Neoplasms; Paclitaxel; Verapamil | 2019 |
Carbon dot festooned and surface passivated graphene-reinforced chitosan construct for tumor-targeted delivery of TNF-α gene.
Topics: Carbon; Chitosan; Gene Transfer Techniques; Genetic Therapy; Graphite; HeLa Cells; Humans; Nanoparticles; Neoplasms; Tumor Necrosis Factor-alpha | 2019 |
Toward Highly Efficient Cancer Imaging and Therapy Using the Environment-Friendly Chitosan Nanoparticles and NIR Laser.
Topics: Caco-2 Cells; Cell Survival; Chitosan; Green Chemistry Technology; Humans; Inhibitory Concentration 50; Lasers; Nanoparticles; Neoplasms; Particle Size; Spectroscopy, Fourier Transform Infrared; Spectroscopy, Near-Infrared; Static Electricity | 2019 |
Novel chitosan based nanoparticles as gene delivery systems to cancerous and noncancerous cells.
Topics: Cell Line, Tumor; Chitosan; DNA; Gene Transfer Techniques; HEK293 Cells; Humans; MCF-7 Cells; Nanoparticles; Neoplasms; Particle Size; Plasmids; Polymers; Transfection | 2019 |
Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
Topics: Animals; Biocompatible Materials; Cell Death; Cell Line, Tumor; Cell Survival; Chitosan; Curcumin; Drug Liberation; Erythrocytes; Ferric Compounds; Fluorouracil; Folic Acid; Hemolysis; Humans; Magnetic Resonance Imaging; Magnetics; Metal-Organic Frameworks; Mice; Mice, Inbred BALB C; Nanocomposites; Neoplasms; NIH 3T3 Cells; Phantoms, Imaging; Protein Corona; Theranostic Nanomedicine; X-Ray Diffraction | 2019 |
Redox-sensitive micelles based on retinoic acid modified chitosan conjugate for intracellular drug delivery and smart drug release in cancer therapy.
Topics: Antineoplastic Agents; Cell Survival; Chitosan; Cystamine; Drug Carriers; Drug Liberation; Hep G2 Cells; Humans; Micelles; Neoplasms; Oxidation-Reduction; Paclitaxel; Particle Size; Tretinoin | 2019 |
Mesenchymal stem cells-curcumin loaded chitosan nanoparticles hybrid vectors for tumor-tropic therapy.
Topics: Animals; Biotin; Cell Movement; Cell Survival; Chitosan; Curcumin; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fluorescent Antibody Technique; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Nanoparticles; Neoplasms; Polymers; Tumor Burden; Xenograft Model Antitumor Assays | 2019 |
A glutathione responsive nitric oxide release system based on charge-reversal chitosan nanoparticles for enhancing synergistic effect against multidrug resistance tumor.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Death; Chitosan; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Endocytosis; Female; Glutathione; Humans; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Nitric Oxide | 2019 |
Synthesis of surface modified Fe
Topics: Chitosan; Ferrosoferric Oxide; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Microscopy, Electron, Transmission; Neoplasms; Particle Size; Spectroscopy, Fourier Transform Infrared; Surface Properties; Ultrasonography | 2019 |
Host-Guest Interactions Initiated Supramolecular Chitosan Nanogels for Selective Intracellular Drug Delivery.
Topics: A549 Cells; Chitosan; Doxorubicin; Drug Delivery Systems; Gels; Humans; Nanostructures; Neoplasms | 2019 |
Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression.
Topics: Absorption; Animals; Antineoplastic Agents; Caco-2 Cells; Carbocyanines; Carcinoma, Lewis Lung; Cell Death; Cell Proliferation; Chitosan; Drug Delivery Systems; Endocytosis; Flow Cytometry; Gene Silencing; Gene Transfer Techniques; Humans; Intracellular Space; Male; Mice; Nanoparticles; Neoplasms; Paclitaxel; Permeability; Quaternary Ammonium Compounds; RNA, Small Interfering; Telomerase; Tissue Distribution; Xenograft Model Antitumor Assays | 2013 |
Specific tumor delivery of paclitaxel using glycolipid-like polymer micelles containing gold nanospheres.
Topics: Ablation Techniques; Animals; Cell Death; Cell Line, Tumor; Chitosan; Diagnostic Imaging; Drug Delivery Systems; Endocytosis; Glycolipids; Gold; Humans; Light; Mice; Micelles; Nanospheres; Neoplasms; Oligosaccharides; Paclitaxel; Particle Size; Peptides; Polymers; Receptor, EphB4; Spectroscopy, Near-Infrared; Static Electricity; Stearic Acids; Temperature | 2013 |
Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles.
Topics: Animals; Antibiotics, Antineoplastic; Boronic Acids; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Male; Mice; Nanoparticles; Neoplasms; Oligopeptides; Spheroids, Cellular; Tumor Cells, Cultured | 2013 |
Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy.
Topics: Adaptive Immunity; Adenoviridae; Animals; Chitosan; Folic Acid; Genetic Therapy; Male; Mice; Mice, Nude; Neoplasms; Oncolytic Virotherapy; Oncolytic Viruses; Polyethylene Glycols | 2013 |
Folic acid conjugated glycol chitosan micelles for targeted delivery of doxorubicin: preparation and preliminary evaluation in vitro.
Topics: Antibiotics, Antineoplastic; Cell Survival; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; HeLa Cells; Humans; Micelles; Neoplasms | 2013 |
Effect of binding affinity for siRNA on the in vivo antitumor efficacy of polyplexes.
Topics: Animals; Antineoplastic Agents; Apoptosis; Body Weight; Cell Line, Tumor; Chitosan; Cysteine; Female; Galactose; Gene Silencing; Humans; Intracellular Space; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Scanning; Neoplasms; Particle Size; Platelet Endothelial Cell Adhesion Molecule-1; Polymers; RNA, Small Interfering; Static Electricity; Tissue Distribution; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |
Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Down-Regulation; Electrophoretic Mobility Shift Assay; Endocytosis; Female; Humans; Inhibitor of Apoptosis Proteins; Luciferases; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Particle Size; Peptides; Repressor Proteins; RNA, Small Interfering; Spectroscopy, Fourier Transform Infrared; Survivin; Wound Healing | 2013 |
In vitro characterization of magnetic electrospun IDA-grafted chitosan nanofiber composite for hyperthermic tumor cell treatment.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Chitosan; Hyperthermia, Induced; Imino Acids; Magnetics; Magnetite Nanoparticles; Materials Testing; Mice; Models, Biological; Nanocomposites; Nanofibers; Neoplasms | 2013 |
Synthesis, in vitro and in vivo evaluation of new norcantharidin-conjugated hydroxypropyltrimethyl ammonium chloride chitosan derivatives as polymer therapeutics.
Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Chitosan; Endocytosis; Humans; Male; Mice; Neoplasms; Polymers; Quaternary Ammonium Compounds | 2013 |
Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice.
Topics: Animals; Chitosan; Chlorophyll; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Oxidation-Reduction; Photochemotherapy; Radiation-Sensitizing Agents | 2013 |
Properties and evaluation of quaternized chitosan/lipid cation polymeric liposomes for cancer-targeted gene delivery.
Topics: Animals; Cations; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gene Transfer Techniques; Genetic Vectors; Hep G2 Cells; Humans; Lipids; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Particle Size; Polymers; Structure-Activity Relationship; Surface Properties | 2013 |
Gadolinium-loaded chitosan nanoparticles as magnetic resonance imaging contrast agents for the diagnosis of tumor.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chitosan; Contrast Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gadolinium; Magnetic Resonance Imaging; Melanoma, Experimental; Mice; Nanoparticles; Neoplasms; Radiography; Skin Neoplasms | 2013 |
DNA interaction of [Cu(dmp)(phen-dion)] (dmp=4,7 and 2,9 dimethyl phenanthroline, phen-dion=1,10-phenanthroline-5,6-dion) complexes and DNA-based electrochemical biosensor using chitosan-carbon nanotubes composite film.
Topics: Antineoplastic Agents; Biosensing Techniques; Cell Line, Tumor; Cell Survival; Chitosan; Coordination Complexes; Copper; DNA; Electrochemical Techniques; Humans; Nanotubes, Carbon; Neoplasms; Nucleic Acid Denaturation; Phenanthrolines | 2013 |
Tumor-targeting nanogel that can function independently for both photodynamic and photothermal therapy and its synergy from the procedure of PDT followed by PTT.
Topics: Animals; Chitosan; Chlorophyllides; Gels; Gold; Male; Mice; Mice, Nude; Nanotubes; Neoplasms; Photosensitizing Agents; Phototherapy; Poloxamer; Porphyrins; Tumor Burden | 2013 |
CMCTS stabilized Fe3O4 particles with extremely low toxicity as highly efficient near-infrared photothermal agents for in vivo tumor ablation.
Topics: Animals; Cattle; Cell Line; Cell Survival; Chitosan; Drug Carriers; Ferrosoferric Oxide; Gold; Humans; Infrared Rays; Magnetic Resonance Imaging; Magnetite Nanoparticles; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanospheres; Neoplasms; Photosensitizing Agents; Serum Albumin, Bovine; Temperature; Tissue Distribution | 2013 |
Self-assembled phytosterol-fructose-chitosan nanoparticles as a carrier of anticancer drug.
Topics: Antineoplastic Agents; Chemistry, Pharmaceutical; Chitosan; Doxorubicin; Drug Carriers; Fructose; Humans; Hydrogen-Ion Concentration; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Neoplasms; Phytosterols; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared | 2013 |
Electrochemical immunosensor for simultaneous detection of multiplex cancer biomarkers based on graphene nanocomposites.
Topics: alpha-Fetoproteins; Biosensing Techniques; Carcinoembryonic Antigen; Chitosan; Electrochemical Techniques; Gold; Graphite; Humans; Immunoassay; Nanocomposites; Nanoparticles; Neoplasms | 2013 |
Biocompatible glycol chitosan-coated gold nanoparticles for tumor-targeting CT imaging.
Topics: Animals; Biocompatible Materials; Cell Survival; Chitosan; Contrast Media; Gold; Humans; Liver Neoplasms; Metal Nanoparticles; Mice; Neoplasms; Radiography; Tissue Distribution | 2014 |
Gd-labeled glycol chitosan as a pH-responsive magnetic resonance imaging agent for detecting acidic tumor microenvironments.
Topics: Acids; Animals; Chitosan; Contrast Media; Gadolinium; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Structure; Neoplasms; NIH 3T3 Cells; Radiography; Reproducibility of Results; Sensitivity and Specificity; Succinimides; Tumor Microenvironment | 2013 |
Formulation development and evaluation of hybrid nanocarrier for cancer therapy: Taguchi orthogonal array based design.
Topics: Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms; Particle Size; Serum Albumin, Bovine | 2013 |
Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; HeLa Cells; Humans; Male; Methotrexate; Mice; Nanoparticles; Neoplasms; Particle Size; Polyethylene Glycols | 2014 |
Hypoxia-sensitive bis(2-(2'-benzothienyl)pyridinato-N,C(3'))iridium[poly(n-butyl cyanoacrylate]/chitosan nanoparticles and their phosphorescence tumor imaging in vitro and in vivo.
Topics: Animals; Cell Hypoxia; Cells, Cultured; Chitosan; Coordination Complexes; Drug Carriers; Enbucrilate; HeLa Cells; Humans; Iridium; Luminescent Agents; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; Nanoparticles; Neoplasms; Oxygen | 2013 |
Quaternized chitosan-coated nanofibrous implants loaded with gossypol prepared by electrospinning and their efficacy against Graffi myeloid tumor.
Topics: Animals; Antineoplastic Agents; Cell Death; Chitosan; Cricetinae; Drug Carriers; Drug Implants; Gossypol; Leukemia Virus, Murine; Nanofibers; Nanotechnology; Neoplasms; Polyesters; Polyethylene Glycols | 2014 |
Simultaneous RGB emitting Au nanoclusters in chitosan nanoparticles for anticancer gene theranostics.
Topics: Biopolymers; Chitosan; Flow Cytometry; Gold; HeLa Cells; Humans; Hydrogen-Ion Concentration; Microscopy, Electron, Transmission; Nanoparticles; Neoplasms; Spectrometry, Fluorescence; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Delivery Systems; Folic Acid; Folic Acid Transporters; Humans; Nanoparticles; Neoplasm Proteins; Neoplasms; Phagocytosis | 2013 |
Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction.
Topics: Cell Line, Tumor; Chitosan; Combined Modality Therapy; Curcumin; Humans; Hyperthermia, Induced; Intracellular Space; Magnetic Resonance Spectroscopy; Nanoparticles; Neoplasms; Particle Size; Poloxamer; Temperature | 2014 |
Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Humans; Nanoparticles; Neoplasms; Polyesters | 2014 |
pH-controllable drug carrier with SERS activity for targeting cancer cells.
Topics: Antibiotics, Antineoplastic; Cell Line; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Delivery Systems; HeLa Cells; Humans; Hydrogen-Ion Concentration; Nanoparticles; Neoplasms; Polymethacrylic Acids; Silicon Dioxide; Silver; Spectrum Analysis, Raman; Surface Properties | 2014 |
Coupling of a bifunctional peptide R13 to OTMCS-PEI copolymer as a gene vector increases transfection efficiency and tumor targeting.
Topics: Animals; Cattle; Chitosan; Genes, Reporter; Genetic Vectors; HeLa Cells; Humans; Nanomedicine; Nanoparticles; Nanotechnology; Neoplasms; Particle Size; Peptides; Plasmids; Polyethyleneimine; Transfection | 2014 |
Studies on drug-polymer interaction, in vitro release and cytotoxicity from chitosan particles excipient.
Topics: Angiogenesis Inhibitors; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Cross-Linking Reagents; Crystallography, X-Ray; Delayed-Action Preparations; Drug Carriers; Excipients; Humans; Hydrophobic and Hydrophilic Interactions; Lenalidomide; Light; MCF-7 Cells; Microscopy, Electron, Transmission; Nanoparticles; Neoplasms; Particle Size; Powder Diffraction; Scattering, Radiation; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; Thalidomide; Thermogravimetry | 2014 |
Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake.
Topics: Antineoplastic Agents; Cations; Cell Survival; Chitosan; Curcumin; Delayed-Action Preparations; HeLa Cells; Humans; Nanoparticles; Neoplasms; Polyesters | 2012 |
Chitosan-coated gold nanorods for cancer therapy combining chemical and photothermal effects.
Topics: Chitosan; Doxorubicin; Drug Delivery Systems; Gold; Humans; Materials Testing; MCF-7 Cells; Nanotubes; Neoplasms; Spectrophotometry, Ultraviolet | 2014 |
Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles.
Topics: Animals; Antigens, Neoplasm; Chitosan; Copper; CpG Islands; Cytokines; Female; Hyperthermia, Induced; Immunotherapy; Infrared Rays; Lasers; Light; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nanotechnology; Neoplasms; Oligonucleotides; Phototherapy; Sulfides | 2014 |
Efficient pH dependent drug delivery to target cancer cells by gold nanoparticles capped with carboxymethyl chitosan.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Delivery Systems; Gold; Humans; Nanoparticles; Neoplasms; Particle Size | 2014 |
Chitosan-based hybrid nanocomplex for siRNA delivery and its application for cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Gene Silencing; Humans; Mice; Microscopy, Electron, Transmission; Nanostructures; Neoplasms; Particle Size; RNA, Small Interfering; Transfection; Xenograft Model Antitumor Assays | 2014 |
A disposable indium-tin-oxide sensor modified by gold nanorod-chitosan nanocomposites for the detection of H₂O₂ in cancer cells.
Topics: Catalysis; Chitosan; Gold; Hydrogen Peroxide; Limit of Detection; Nanotubes; Neoplasms; Tin Compounds | 2014 |
Facile synthesis of multilayered polysaccharidic vesicles.
Topics: Amylases; Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Carriers; Female; Folic Acid; Folic Acid Transporters; Humans; Hyaluronic Acid; Mice, Nude; Neoplasms; Peptides; Polyethylene Glycols; Polylysine; Serum Albumin, Bovine; Starch | 2014 |
Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy.
Topics: Apoptosis; Bortezomib; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Delivery Systems; Drug Stability; Endocytosis; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Inhibitory Concentration 50; Magnetite Nanoparticles; Neoplasms; Spectroscopy, Fourier Transform Infrared | 2014 |
Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Chitosan; Delayed-Action Preparations; Hep G2 Cells; Humans; Intestinal Absorption; Male; Mice; Micelles; Neoplasms; Paclitaxel; Quercetin; Rats; Rats, Sprague-Dawley; Solubility | 2014 |
PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Topics: Animals; Anions; Apoptosis; Calcium Phosphates; Chitosan; Endocytosis; Gene Expression Regulation, Neoplastic; Gene Silencing; Gene Transfer Techniques; Hep G2 Cells; Humans; Intracellular Space; Light; Luciferases; Luminescent Measurements; Mice, Nude; Nanoparticles; Neoplasms; Particle Size; RNA, Messenger; RNA, Small Interfering; Scattering, Radiation; Static Electricity; Telomerase; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |
A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cell Line, Tumor; Chitosan; DNA; Drug Delivery Systems; Gene Transfer Techniques; Genes, p53; Genetic Therapy; Humans; Male; Mice, Inbred BALB C; Neoplasms; Neovascularization, Pathologic; Polyethyleneimine; Receptor, Angiotensin, Type 1; Tetrazoles | 2014 |
pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate.
Topics: Antimetabolites, Antineoplastic; Cell Survival; Chitosan; Delayed-Action Preparations; HeLa Cells; Humans; Hydrogen-Ion Concentration; Methotrexate; Nanoparticles; Neoplasms; Oxidation-Reduction; Sulfhydryl Compounds | 2014 |
Chitosan as an adjuvant-like substrate for dendritic cell culture to enhance antitumor effects.
Topics: Adjuvants, Immunologic; Animals; Biocompatible Materials; Cancer Vaccines; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Chitosan; Dendritic Cells; Humans; Mice; Mice, Inbred C57BL; Monocytes; Neoplasms | 2014 |
Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
Topics: Alginates; Animals; Antineoplastic Agents; Carbohydrate Sequence; Chitosan; Drug Carriers; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Humans; Molecular Sequence Data; Nanoparticles; Neoplasms; Particle Size | 2014 |
Folate-targeted multifunctional amino acid-chitosan nanoparticles for improved cancer therapy.
Topics: Amino Acids; Antineoplastic Agents; Chitosan; Coculture Techniques; Drug Carriers; Drug Delivery Systems; Folic Acid; HeLa Cells; Humans; Nanoparticles; Neoplasms | 2015 |
Self-aggregated nanoparticles of carboxylic curdlan-deoxycholic acid conjugates as a carrier of doxorubicin.
Topics: Antineoplastic Agents; beta-Glucans; Cell Line, Tumor; Chitosan; Deoxycholic Acid; Doxorubicin; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Neoplasms | 2015 |
Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; Cell Survival; Chitosan; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Silencing; Humans; MCF-7 Cells; Mice, Nude; Nanoparticles; Neoplasms; RNA, Small Interfering; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Anti-cancer, pharmacokinetics and tumor localization studies of pH-, RF- and thermo-responsive nanoparticles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caprolactam; Cell Line, Tumor; Chitosan; Curcumin; Disease Models, Animal; Drug Delivery Systems; Gold; Humans; Hydrogen-Ion Concentration; Mice; Nanoparticles; Neoplasms; Particle Size; Pulsed Radiofrequency Treatment; Thermodynamics; Tissue Distribution; Tumor Burden | 2015 |
An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells.
Topics: Artificial Organs; Blood Vessels; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cellulose; Chitosan; Humans; Lab-On-A-Chip Devices; Models, Biological; Neoplasms; Particle Size; Porosity; Surface Properties; Tumor Microenvironment | 2015 |
Cellular uptake, antioxidant and antiproliferative activity of entrapped α-tocopherol and γ-tocotrienol in poly (lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA nanoparticles (PLGA-Chi).
Topics: alpha-Tocopherol; Antineoplastic Agents; Antioxidants; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Chitosan; Chromans; Humans; Lactic Acid; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2015 |
Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Chitosan; Doxorubicin; Drug Carriers; Erythrocyte Membrane; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Fields; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Neoplasms; Oligopeptides; Paclitaxel; Polyethylene Glycols; Survival Rate; Tissue Distribution | 2015 |
High molecular weight chitosan derivative polymeric micelles encapsulating superparamagnetic iron oxide for tumor-targeted magnetic resonance imaging.
Topics: Animals; Chitosan; Contrast Media; Folic Acid; HeLa Cells; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Micelles; Neoplasms | 2015 |
Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.
Topics: Animals; Antineoplastic Agents; Chitosan; Chromatography, Liquid; Disulfides; Doxorubicin; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Microscopy, Confocal; Neoplasms; Oligosaccharides; Oxidation-Reduction; Particle Size; Polymers; Stearic Acids | 2015 |
Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
Topics: Animals; Antineoplastic Agents; Apoptosis; Chitosan; Chromatography, High Pressure Liquid; Cytoplasm; Cytosol; Drug Carriers; Drug Delivery Systems; Drug Liberation; Hep G2 Cells; Hepatocytes; Humans; Hydrogen-Ion Concentration; Lysosomes; Male; Mice; Mice, Inbred ICR; Microscopy, Confocal; Mitochondria; Nanoparticles; Nanotechnology; Neoplasm Transplantation; Neoplasms; Rats; Rats, Wistar; Schiff Bases; Strychnine | 2015 |
Codelivery of paclitaxel and small interfering RNA by octadecyl quaternized carboxymethyl chitosan-modified cationic liposome for combined cancer therapy.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cations; Chitosan; Drug Carriers; Liposomes; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Neoplasms; Paclitaxel; RNA, Small Interfering; Spectroscopy, Fourier Transform Infrared | 2015 |
Docetaxel-loaded solid lipid nanoparticles as a basis for a targeted and dose-sparing personalized breast cancer treatment strategy.
Topics: Animals; Antineoplastic Agents; Chitosan; Drug Carriers; Humans; Male; Nanoparticles; Neoplasms; Taxoids | 2015 |
Photothermal tumor ablation in mice with repeated therapy sessions using NIR-absorbing micellar hydrogels formed in situ.
Topics: Animals; Cell Line, Tumor; Chitosan; Humans; Hydrogels; Hydrogen-Ion Concentration; Infrared Rays; Light; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Micelles; Nanospheres; Neoplasm Transplantation; Neoplasms; Phase Transition; Phenylenediamines; Phototherapy; Polymers; Scattering, Radiation; Spectrophotometry, Ultraviolet; Viscosity | 2015 |
Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.
Topics: Cell Line, Tumor; Cell Survival; Chitosan; Diagnostic Imaging; Drug Delivery Systems; Ferric Compounds; Humans; Methotrexate; Nanocomposites; Nanoparticles; Neoplasms; Polyethylene Glycols | 2015 |
Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Delivery Systems; Female; Galactose; Gene Products, tat; Humans; Hydrogen-Ion Concentration; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Oxidation-Reduction; Polyamines; RNA, Small Interfering; RNAi Therapeutics; Silicon Dioxide; Vascular Endothelial Growth Factor A | 2015 |
Production of 4-ipomeanol, an anticancer agent from the root tubers and rhizogenic callus of Ipomoea batatas Lam.: a comparative study.
Topics: Antineoplastic Agents; Bony Callus; Chitin; Chitosan; Humans; Ipomoea batatas; Neoplasms; Plant Roots; Terpenes | 2015 |
Optimization of Surface Coating on Small Pd Nanosheets for in Vivo near-Infrared Photothermal Therapy of Tumor.
Topics: Animals; Biocompatible Materials; Chitosan; Female; Mice; Nanostructures; Neoplasms; Palladium; Phototherapy; Polyethylene Glycols; Spectrophotometry, Infrared; Surface Properties; Thermography; Tissue Distribution | 2015 |
Targeting delivery of tocopherol and doxorubicin grafted-chitosan polymeric micelles for cancer therapy: In vitro and in vivo evaluation.
Topics: Cell Line, Tumor; Chitosan; Doxorubicin; Drug Delivery Systems; HEK293 Cells; Humans; In Vitro Techniques; Micelles; Neoplasms; Polymers; Tocopherols | 2015 |
Characterization of vitamin-cisplatin-loaded chitosan nano-particles for chemoprevention and cancer fatigue.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antineoplastic Agents; Biological Assay; Cattle; Cell Proliferation; Chitosan; Cisplatin; Fatigue; Humans; Metal Nanoparticles; Microscopy, Electron, Scanning; Nanoparticles; Neoplasms; Particle Size; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared; Vitamins | 2015 |
Folate-conjugated chitosan-poly(ethylenimine) copolymer as an efficient and safe vector for gene delivery in cancer cells.
Topics: Animals; Aziridines; Cell Line, Tumor; Chitosan; Folate Receptors, GPI-Anchored; Folic Acid; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Melanoma, Experimental; Mice; Neoplasms; Polymers; Transfection | 2015 |
Target gene delivery from targeting ligand conjugated chitosan-PEI copolymer for cancer therapy.
Topics: Cell Line, Tumor; Cell Survival; Chitosan; DNA; Gene Transfer Techniques; Genetic Therapy; Humans; Neoplasms; Plasmids; Polyethyleneimine; Receptor, ErbB-2; RNA, Small Interfering | 2016 |
Bioengineered quantum dot/chitosan-tripeptide nanoconjugates for targeting the receptors of cancer cells.
Topics: Biocompatible Materials; Cell Line, Tumor; Chitosan; Humans; Materials Testing; Molecular Imaging; Nanoconjugates; Neoplasms; Oligopeptides; Protein Binding; Quantum Dots; Receptors, Cell Surface; Spectroscopy, Fourier Transform Infrared | 2016 |
Nanocomposite hydrogel incorporating gold nanorods and paclitaxel-loaded chitosan micelles for combination photothermal-chemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Combined Modality Therapy; Drug Carriers; Drug Stability; Gold; Hydrogels; Hyperthermia, Induced; Injections, Intralesional; Laser Therapy; Male; Mice; Micelles; Nanocomposites; Nanotubes; Neoplasms; Paclitaxel; Phototherapy; Xenograft Model Antitumor Assays | 2016 |
Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Chitosan; Deoxyribonuclease I; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Electrophoresis, Agar Gel; Endocytosis; Flow Cytometry; Gefitinib; HeLa Cells; Humans; Intracellular Space; Nanoparticles; Neoplasms; Particle Size; Quinazolines; RNA, Small Interfering; Transfection | 2015 |
Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
Topics: Animals; Chitosan; Disease Models, Animal; Male; Mice, Inbred BALB C; Mice, Inbred C3H; Nanoparticles; Neoplasms; Theranostic Nanomedicine; Ultrasonography | 2015 |
Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method.
Topics: Amino Acid Transport System ASC; Animals; Cell Cycle Proteins; Cell Line, Tumor; Chitosan; Female; Green Fluorescent Proteins; Humans; Ligands; Mice, Nude; Minor Histocompatibility Antigens; Molecular Structure; Nanoparticles; Neoplasms; Oligopeptides; Oncogene Proteins; Polyethylene Glycols; RNA, Small Interfering | 2016 |
Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
Topics: Animals; Cell Line, Tumor; Chitosan; Female; Gene Transfer Techniques; Mice; Nanoparticles; Neoplasms; Ovarian Neoplasms; RNA, Small Interfering; RNAi Therapeutics | 2016 |
Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Chitosan; Doxorubicin; Drug Compounding; Drug Design; Drug Liberation; Folic Acid; Folic Acid Transporters; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Magnetic Phenomena; Magnetite Nanoparticles; MCF-7 Cells; Mice; Neoplasms; NIH 3T3 Cells; Theranostic Nanomedicine | 2016 |
In vitro study on apoptotic cell death by effective magnetic hyperthermia with chitosan-coated MnFe₂O₄.
Topics: Apoptosis; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Chitosan; Ferric Compounds; Humans; Hyperthermia, Induced; In Vitro Techniques; Magnetite Nanoparticles; Manganese Compounds; Neoplasms | 2016 |
A magnetic vehicle realized tumor cell-targeted radiotherapy using low-dose radiation.
Topics: Animals; Chitosan; Chlorophyllides; Drug Delivery Systems; Female; Ferric Compounds; Folic Acid; HeLa Cells; Humans; Magnets; Mice, Nude; Micelles; Neoplasms; Porphyrins; Radiation-Sensitizing Agents | 2016 |
Targeted DNA delivery to cancer cells using a biotinylated chitosan carrier.
Topics: Biotin; Chitosan; Gene Transfer Techniques; Green Fluorescent Proteins; HeLa Cells; Humans; Neoplasms; Plasmids | 2017 |
Effective co-delivery of doxorubicin and curcumin using a glycyrrhetinic acid-modified chitosan-cystamine-poly(ε-caprolactone) copolymer micelle for combination cancer chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Chitosan; Curcumin; Cystamine; Doxorubicin; Drug Liberation; Endocytosis; Flow Cytometry; Glycyrrhetinic Acid; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen-Ion Concentration; Intracellular Space; Micelles; Neoplasms; Polyesters; Spectroscopy, Fourier Transform Infrared | 2016 |
A smart multifunctional drug delivery nanoplatform for targeting cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Drug Liberation; Fluorescein; Gold; Humans; Hydrogels; Hydrogen-Ion Concentration; Isothiocyanates; Metal Nanoparticles; Neoplasms; Nickel | 2016 |
Carbon Dots Embedded Magnetic Nanoparticles @Chitosan @Metal Organic Framework as a Nanoprobe for pH Sensitive Targeted Anticancer Drug Delivery.
Topics: Antineoplastic Agents; Carbon; Cell Line; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; HeLa Cells; Humans; Hydrogen-Ion Concentration; Magnetite Nanoparticles; Metal-Organic Frameworks; Neoplasms | 2016 |
Physicochemical investigations of biogenic chitosan-silver nanocomposite as antimicrobial and anticancer agent.
Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Cell Line, Tumor; Chitosan; Drug Screening Assays, Antitumor; Humans; Nanocomposites; Neoplasms; Silver | 2016 |
Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Liberation; Humans; Hydrogels; Mice, Inbred ICR; Neoplasms; Polyethylene Glycols; Tumor Burden | 2016 |
Predicting the in vivo accumulation of nanoparticles in tumor based on in vitro macrophage uptake and circulation in zebrafish.
Topics: Animals; Biological Transport; Blood Circulation; Cell Line, Tumor; Chitosan; Dextrans; Female; Humans; Hyaluronic Acid; Macrophages; Mice; Mice, Inbred C3H; Microscopy, Electron, Transmission; Nanoparticles; Neoplasms; Polystyrenes; RAW 264.7 Cells; Titanium; Zebrafish | 2016 |
Porphyrin dye into biopolymeric chitosan films for localized photodynamic therapy of cancer.
Topics: Cell Survival; Chitosan; Coloring Agents; Drug Carriers; Drug Liberation; Fluorescence; Gelatin; HeLa Cells; Humans; Light; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Porphyrins | 2016 |
Polydopamine/dialdehyde starch/chitosan composite coating for in-tube solid-phase microextraction and in-situ derivation to analysis of two liver cancer biomarkers in human blood.
Topics: Aged; Biomarkers, Tumor; Chitosan; Female; Humans; Indoles; Male; Middle Aged; Neoplasms; Particle Size; Polymers; Solid Phase Microextraction; Starch | 2016 |
Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Cell Proliferation; Cells, Cultured; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Fibroblasts; HeLa Cells; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Mice; Nanoparticles; Neoplasms; Polyphosphates; Surface-Active Agents | 2016 |
Facile Fabrication of Near-Infrared-Responsive and Chitosan-Functionalized Cu
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Chitosan; Copper; HeLa Cells; Humans; Infrared Rays; Metal Nanoparticles; Microscopy, Electron, Transmission; Neoplasms; Particle Size; Phototherapy; Reactive Oxygen Species; Selenium; Solubility; Temperature | 2016 |
Paclitaxel loaded magnetic nanocomposites with folate modified chitosan/carboxymethyl surface; a vehicle for imaging and targeted drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Chitosan; Drug Delivery Systems; Drug Liberation; Erythrocytes; Ferric Compounds; Folic Acid; Hemolysis; Humans; Magnetic Phenomena; MCF-7 Cells; Nanocomposites; Neoplasms; Nickel; Paclitaxel; Serum Albumin, Bovine | 2016 |
Improved specific loss power on cancer cells by hyperthermia and MRI contrast of hydrophilic Fe
Topics: Animals; Cell Line, Tumor; Chitosan; Coated Materials, Biocompatible; Cobalt; Contrast Media; Ferric Compounds; Fever; Humans; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Necrosis; Neoplasms; Polyethylene Glycols; Rats | 2016 |
Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Topics: Animals; Cell Proliferation; Cell Survival; Chitosan; Collagen; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Flow Cytometry; HeLa Cells; Humans; Hydrogen-Ion Concentration; Mice; Nanoparticles; Neoplasms; NIH 3T3 Cells; Particle Size; Peptides; Spectroscopy, Fourier Transform Infrared; Time Factors; X-Ray Diffraction | 2017 |
Targeted drug delivery of Sunitinib Malate to tumor blood vessels by cRGD-chiotosan-gold nanoparticles.
Topics: Cell Survival; Cells, Cultured; Chitosan; Drug Carriers; Drug Liberation; Gold; Humans; Indoles; Nanoparticles; Neoplasms; Particle Size; Peptides, Cyclic; Pyrroles; Sunitinib; Surface Properties | 2017 |
Biocompatible electrospinning chitosan nanofibers: A novel delivery system with superior local cancer therapy.
Topics: Antineoplastic Agents; Bacteria; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Chitosan; Drug Delivery Systems; Drug Liberation; Humans; Nanofibers; Neoplasms | 2017 |
Lactate Detection in Tumor Cell Cultures Using Organic Transistor Circuits.
Topics: Animals; Biosensing Techniques; Calibration; Cattle; Cell Culture Techniques; Chitosan; Electric Impedance; Electrochemical Techniques; Equipment Design; Ferrous Compounds; Humans; Lactic Acid; Leukocytes, Mononuclear; Metallocenes; Mixed Function Oxygenases; Neoplasms; Polystyrenes; Sensitivity and Specificity; Serum Albumin, Bovine; Thiophenes; Transistors, Electronic | 2017 |
A semiautomated microfluidic platform for real-time investigation of nanoparticles' cellular uptake and cancer cells' tracking.
Topics: Cell Survival; Chitosan; Dendrimers; Drug Carriers; Endocytosis; HeLa Cells; Humans; Microfluidics; Nanoparticles; Neoplasms | 2017 |
Construction and in vitro evaluation of enzyme nanoreactors based on carboxymethyl chitosan for arginine deprivation in cancer therapy.
Topics: Arginine; Chitosan; Enzymes; Hydrolases; Micelles; Nanotechnology; Neoplasms | 2017 |
Multifunctional biocompatible chitosan-polypyrrole nanocomposites as novel agents for photoacoustic imaging-guided photothermal ablation of cancer.
Topics: Animals; Cell Line, Tumor; Chitosan; Disease Models, Animal; Female; Humans; Hyperthermia, Induced; Mice; Nanocomposites; Neoplasms; Photoacoustic Techniques; Phototherapy; Polymers; Pyrroles; Xenograft Model Antitumor Assays | 2017 |
Extracellular matrix remodeling in vivo for enhancing tumor-targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound.
Topics: A549 Cells; Animals; Carbocyanines; Cell Line, Tumor; Chitosan; Drug Carriers; Extracellular Matrix; Fluorescent Dyes; High-Intensity Focused Ultrasound Ablation; Humans; Male; Mice, Nude; Nanoparticles; Neoplasms | 2017 |
Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Chitosan; Colloids; Docetaxel; Drug Delivery Systems; Fluorescent Dyes; Humans; Nanocapsules; Nanoparticles; Nanotechnology; Neoplasms; Taxoids; Time Factors | 2008 |
Inhibitory effects of chitooligosaccharides on tumor growth and metastasis.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Line, Tumor; Chitosan; Coloring Agents; Gelatin; Humans; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, SCID; Molecular Weight; Neoplasm Metastasis; Neoplasms; Oligosaccharides; Tetrazolium Salts; Thiazoles | 2009 |
Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Cholesterol; Doxorubicin; Drug Carriers; Drug Compounding; Light; Male; Mice; Mice, Inbred ICR; Microscopy, Electron, Transmission; Nanoparticles; Neoplasms; Particle Size; Polymers; Rats; Rats, Sprague-Dawley; Scattering, Radiation; Solubility; Xenograft Model Antitumor Assays | 2009 |
Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells.
Topics: Alginates; Cell Death; Cell Survival; Chitosan; Curcumin; Drug Delivery Systems; Glucuronic Acid; HeLa Cells; Hexuronic Acids; Humans; Kinetics; Microscopy, Fluorescence; Nanocomposites; Nanoparticles; Neoplasms; Particle Size; Poloxamer; Spectroscopy, Fourier Transform Infrared | 2010 |
Effect of chitosan-alginate nanoparticles and ultrasound on the efficiency of gene transfection of human cancer cells.
Topics: Alginates; Animals; Cell Death; Chitosan; DNA; Electrophoresis, Agar Gel; Glucuronic Acid; HeLa Cells; Hexuronic Acids; Humans; Mice; Microscopy, Fluorescence; Nanoparticles; Neoplasms; Plasmids; Transfection; Ultrasonics | 2010 |
Gene-carried chitosan-linked-PEI induced high gene transfection efficiency with low toxicity and significant tumor-suppressive activity.
Topics: Animals; Cell Line, Tumor; Chitosan; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Mice; Mice, Inbred ICR; Microscopy, Confocal; Neoplasm Transplantation; Neoplasms; Particle Size; Polyethyleneimine; Transfection | 2010 |
The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Heparin; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Neoplasms; NIH 3T3 Cells; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2010 |
Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
Topics: Cations; Cell Line, Tumor; Chitosan; Cholesterol; Drug Delivery Systems; Flow Cytometry; Fluoresceins; Folic Acid; Humans; Hydrogen-Ion Concentration; Kinetics; Liposomes; Magnetic Resonance Spectroscopy; Micelles; Microscopy, Fluorescence; Neoplasms; Particle Size; Permeability; Polyethylene Glycols; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Time Factors | 2010 |
Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Design; Humans; Mice; Models, Chemical; Molecular Weight; Nanoparticles; Nanotechnology; Neoplasms | 2010 |
Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
Topics: Animals; Chitosan; Cholic Acids; Hydrophobic and Hydrophilic Interactions; Luminescent Proteins; Male; Mice; Mice, Nude; Nanoparticles; Neoplasms; Polyethyleneimine; Polymers; Red Fluorescent Protein; RNA, Small Interfering | 2010 |
Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.
Topics: Chitosan; Cholic Acids; Fluorescence; Fluorescent Dyes; Gadolinium; Magnetic Resonance Imaging; Nanoparticles; Neoplasms; Spectroscopy, Near-Infrared | 2010 |
A self-organized 3-diethylaminopropyl-bearing glycol chitosan nanogel for tumor acidic pH targeting: in vitro evaluation.
Topics: Amines; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Nanogels; Neoplasms; Particle Size; Polyethylene Glycols; Polyethyleneimine; Solutions | 2010 |
Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
Topics: Animals; Antineoplastic Agents; Chitosan; Doxorubicin; Drug Carriers; Histidine; Hydrophobic and Hydrophilic Interactions; Male; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Nanoparticles; Neoplasms; Radionuclide Imaging; Tissue Distribution; Xenograft Model Antitumor Assays | 2010 |
Ionically crosslinked Ad/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy.
Topics: Adenoviridae; Animals; Chitosan; Folic Acid; Gene Transfer Techniques; Genetic Therapy; Humans; Mice; Microscopy, Electron, Transmission; Neoplasms; Polyethylene Glycols | 2010 |
Preparation, characterisation and anti-tumour activity of Ganoderma lucidum polysaccharide nanoparticles.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Carriers; HeLa Cells; Hep G2 Cells; Humans; Male; Mice; Mice, Inbred ICR; Nanoparticles; Neoplasms; Particle Size; Polyphosphates; Polysaccharides; Reishi; Spleen | 2010 |
Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
Topics: Animals; Cell Line, Tumor; Chitosan; Contrast Media; Dextrans; Drug Carriers; Folic Acid; Humans; Hydrophobic and Hydrophilic Interactions; Light; Macrophages; Magnetic Resonance Imaging; Magnetics; Magnetite Nanoparticles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Mononuclear Phagocyte System; Nanotechnology; Neoplasms; Particle Size; Scattering, Radiation; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical; X-Ray Diffraction | 2011 |
A novel pH-responsive polysaccharidic ionic complex for proapoptotic D-(KLAKLAK)2 peptide delivery.
Topics: Animals; Antineoplastic Agents; Chitosan; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Maleates; Melanoma, Experimental; Mice; Neoplasms; Peptides | 2011 |
3-Diethylaminopropyl-bearing glycol chitosan as a protein drug carrier.
Topics: 1-Propanol; Amines; Animals; Cattle; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Flow Cytometry; Humans; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Nanogels; Neoplasms; Polyethylene Glycols; Polyethyleneimine; Serum Albumin, Bovine | 2011 |
Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system.
Topics: Animals; Cell Line, Tumor; Chitosan; HT29 Cells; Humans; Mice; Mice, Nude; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2011 |
Hydrogel-siRNA for cancer therapy.
Topics: Animals; Chitosan; Gene Silencing; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Mice; Neoplasms; RNA, Small Interfering | 2011 |
Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models.
Topics: Animals; Blood-Brain Barrier; Carbocyanines; Cell Line; Chitosan; Materials Testing; Mice; Mice, Nude; Molecular Imaging; Molecular Structure; Nanoparticles; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Tissue Distribution | 2011 |
Tumor targeted adenovirus nanocomplex ionically crosslinked by chitosan.
Topics: Adenoviridae; Chitosan; Folic Acid; Genetic Therapy; Humans; Nanostructures; Neoplasms; Polyethylene Glycols; Transduction, Genetic | 2010 |
Antitumor efficacy, tumor distribution and blood pharmacokinetics of chitosan/glyceryl-monooleate nanostructures containing paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chitosan; Drug Delivery Systems; Female; Glycerides; Leukocyte Count; Mice; Mice, Inbred BALB C; Nanostructures; Neoplasms; Paclitaxel | 2011 |
Strategies and advances in nanomedicine for targeted siRNA delivery.
Topics: Animals; Chitosan; Humans; Models, Biological; Models, Theoretical; Nanomedicine; Nanoparticles; Neoplasms; Polyethyleneimine; Polymers; RNA, Small Interfering | 2011 |
Highly selective in-vivo imaging of tumor as an inflammation site by ROS detection using hydrocyanine-conjugated, functional nano-carriers.
Topics: Animals; Cell Line; Cell Line, Tumor; Chitosan; Diagnostic Imaging; Inflammation; Male; Mice; Mice, Nude; Nanoparticles; Neoplasms; Poloxamer; Reactive Oxygen Species | 2011 |
Chitosan-coated triangular silver nanoparticles as a novel class of biocompatible, highly effective photothermal transducers for in vitro cancer cell therapy.
Topics: Cell Line, Tumor; Cell Survival; Chitosan; Coated Materials, Biocompatible; Humans; Hyperthermia, Induced; Metal Nanoparticles; Neoplasms; Phototherapy; Silver; Spectroscopy, Near-Infrared | 2011 |
Formulation optimization of chelerythrine loaded O-carboxymethylchitosan microspheres using response surface methodology.
Topics: Algorithms; Antineoplastic Agents; Benzophenanthridines; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drugs, Chinese Herbal; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Microspheres; Models, Statistical; Neoplasms; Particle Size; Regression Analysis; Temperature; Water | 2011 |
Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chitosan; Drug Carriers; Humans; Mice; Mice, Nude; Nanoparticles; Neoplasm Transplantation; Neoplasms; Oligopeptides; Paclitaxel; Receptors, Interleukin-4; Tumor Burden | 2012 |
Tumor-targeting gold particles for dual computed tomography/optical cancer imaging.
Topics: Animals; Chitosan; Contrast Media; Gold; Humans; Matrix Metalloproteinase 2; Metal Nanoparticles; Mice; Neoplasms; Peptides; Spectrophotometry, Ultraviolet; Spectroscopy, Near-Infrared; Substrate Specificity; Surface Plasmon Resonance; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2011 |
Octreotide-modified and pH-triggering polymeric micelles loaded with doxorubicin for tumor targeting delivery.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Chemical Phenomena; Chitosan; Doxorubicin; Drug Carriers; Drug Compounding; Drug Stability; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Male; Micelles; Neoplasms; Octreotide; Polyethylene Glycols; Polymers; Random Allocation; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 2012 |
Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Cell Line, Tumor; Chitosan; Drug Carriers; Heparin; Male; Mice; Microscopy, Electron, Scanning; Nanoparticles; Neoplasm Transplantation; Neoplasms; Paclitaxel; Poloxamer; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Tissue Distribution | 2012 |
Preparation, characterization and cytotoxicity of carbon nanotube-chitosan-phycocyanin complex.
Topics: Biocompatible Materials; Cell Line, Tumor; Cell Survival; Chitosan; Humans; Nanotubes, Carbon; Neoplasms; Photochemotherapy; Photosensitizing Agents; Phycocyanin; Spectrophotometry, Ultraviolet; Thermogravimetry | 2012 |
Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: preparation, characterization and double targeting.
Topics: Animals; Blood Coagulation; Cell Line, Tumor; Chitosan; Embolization, Therapeutic; Factor Xa; Human Umbilical Vein Endothelial Cells; Humans; Magnetic Fields; Magnetite Nanoparticles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanotechnology; Neoplasms; Particle Size; Peptides; Recombinant Fusion Proteins; Spectroscopy, Fourier Transform Infrared; Thromboplastin; Vascular Endothelial Growth Factor Receptor-1; X-Ray Diffraction; Xenograft Model Antitumor Assays | 2012 |
Electrochemical stripping analysis of nanogold label-induced silver deposition for ultrasensitive multiplexed detection of tumor markers.
Topics: alpha-Fetoproteins; Antibodies, Immobilized; Biomarkers, Tumor; Carcinoembryonic Antigen; Chitosan; Electrochemical Techniques; Electrodes; Gold; Humans; Immunoassay; Metal Nanoparticles; Neoplasms; Silver | 2012 |
In vitro feasibility study of the use of a magnetic electrospun chitosan nanofiber composite for hyperthermia treatment of tumor cells.
Topics: Cell Death; Cell Line, Tumor; Chitosan; Enzyme Assays; Feasibility Studies; Fibroblasts; Humans; Hyperthermia, Induced; L-Lactate Dehydrogenase; Magnetics; Nanofibers; Neoplasms; Temperature; Time Factors; Tissue Engineering; Tissue Scaffolds; X-Ray Diffraction | 2012 |
Luminescent/magnetic hybrid nanoparticles with folate-conjugated peptide composites for tumor-targeted drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Cadmium Compounds; Camptothecin; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Folic Acid; Humans; Luminescence; Luminescent Agents; Magnetite Nanoparticles; Micelles; Neoplasms; Oligopeptides; Quantum Dots; Tellurium | 2012 |
Photodynamic therapy using glycol chitosan grafted fullerenes.
Topics: Animals; Cell Line, Tumor; Chitosan; Female; Fullerenes; Humans; Light; Mice; Mice, Nude; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2012 |
Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment.
Topics: Animals; Cell Line, Tumor; Chitosan; Genetic Therapy; Humans; Mice; Nanoparticles; Neoplasms; RNA Interference; RNA, Small Interfering; Sulfhydryl Compounds; Vascular Endothelial Growth Factor A | 2012 |
Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles.
Topics: Animals; Calorimetry, Differential Scanning; Cell Death; Cell Line, Tumor; Chitosan; Chromatography, High Pressure Liquid; Deoxycholic Acid; Doxorubicin; Drug Delivery Systems; Flow Cytometry; Humans; Hydroxylation; Intracellular Space; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Neoplasms; Octreotide; Polyethylene Glycols; Receptors, Somatostatin; Scattering, Radiation; Treatment Outcome; X-Ray Diffraction | 2012 |
The effect of mechanical properties of iron oxide nanoparticle-loaded functional nano-carrier on tumor targeting and imaging.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chitosan; Contrast Media; Drug Carriers; Excipients; Ferric Compounds; Magnetic Resonance Imaging; Male; Metal Nanoparticles; Mice; Mice, Nude; Neoplasms; NIH 3T3 Cells; Poloxamer; Surface-Active Agents | 2012 |
pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Delivery Systems; Glycolipids; Humans; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Molecular Targeted Therapy; Neoplasms; Polyethylene Glycols; Rats; Stearic Acids | 2012 |
In vivo NIRF and MR dual-modality imaging using glycol chitosan nanoparticles.
Topics: Animals; Carbocyanines; Cell Line, Tumor; Chitosan; Fluorescent Dyes; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C3H; Nanoparticles; Neoplasms; Spectrometry, Fluorescence | 2012 |
Effective antitumor gene therapy delivered by polyethylenimine-conjugated stearic acid-g-chitosan oligosaccharide micelles.
Topics: Animals; Chitosan; DNA; Gene Transfer Techniques; Genetic Therapy; HeLa Cells; Humans; MCF-7 Cells; Mice; Micelles; Nanoparticles; Neoplasms; Oligosaccharides; Plasmids; Polyethyleneimine; Stearic Acids | 2013 |
Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic intervention.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antimetabolites, Antineoplastic; Aspartate Aminotransferases; Benzamides; Cell Line, Tumor; Chitosan; Deoxycytidine; Drug Carriers; Female; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Polyethylene Glycols; Tissue Distribution; Urea | 2012 |
Intracellular delivery of docetaxel using freeze-dried polysaccharide nanocapsules.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chitosan; Docetaxel; Drug Delivery Systems; Freeze Drying; Humans; Nanocapsules; Neoplasms; Poloxamer; Taxoids | 2013 |
Near-infrared fluorescing IR820-chitosan conjugate for multifunctional cancer theranostic applications.
Topics: Absorption; Animals; Cell Line, Tumor; Chitosan; Contrast Media; Drug Screening Assays, Antitumor; Feces; Female; Fluorescent Dyes; Humans; Hyperthermia, Induced; Indocyanine Green; Infrared Rays; Injections, Intravenous; Liver; Microscopy, Fluorescence; Neoplasms; Rats; Rats, Inbred F344; Spectroscopy, Fourier Transform Infrared | 2013 |
Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Mice; Mice, Nude; Micelles; Neoplasms; Rats | 2013 |
Medicinal herbs and phytochitodeztherapy in oncology.
Topics: Chitosan; Combined Modality Therapy; Databases, Factual; Female; Follow-Up Studies; Humans; Male; Neoplasms; Phytotherapy; Plant Preparations; Quality of Life; Russia; Survival Analysis; Time Factors; Treatment Outcome | 2003 |
Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chitosan; Chlorocebus aethiops; COS Cells; DNA; Dose-Response Relationship, Drug; Excipients; Female; Gene Transfer Techniques; Genes, Reporter; Humans; Luciferases; Methylation; Neoplasms; Transfection | 2005 |
Preparation and characterization of Mitomycin-C loaded chitosan-coated alginate microspheres for chemoembolization.
Topics: Alginates; Antibiotics, Antineoplastic; Biocompatible Materials; Calcium Chloride; Chemoembolization, Therapeutic; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Drug Compounding; Humans; Microscopy, Electron, Scanning; Microspheres; Mitomycin; Molecular Weight; Neoplasms; Particle Size; Surface Properties | 2005 |
In vivo potentialities of EWS-Fli-1 targeted antisense oligonucleotides-nanospheres complexes.
Topics: Animals; Antineoplastic Agents; Chitosan; CpG Islands; DNA Methylation; Humans; Mice; Mice, Nude; Microscopy, Confocal; Nanotubes; Neoplasm Transplantation; Neoplasms; NIH 3T3 Cells; Oligonucleotides, Antisense; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; RNA-Binding Protein EWS; Time Factors | 2005 |
In vivo antitumor activity of chitosan nanoparticles.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Screening Assays, Antitumor; Humans; Mice; Nanostructures; Nanotechnology; Neoplasms; Particle Size; Time Factors | 2006 |
Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery.
Topics: Carrier Proteins; Chitosan; DNA; Drug Carriers; Folate Receptors, GPI-Anchored; Folic Acid; Gene Transfer Techniques; Genetic Vectors; Humans; Hydrogen-Ion Concentration; Models, Chemical; Neoplasms; Plasmids; Polyethylene Glycols; Receptors, Cell Surface; Solubility; Water | 2007 |
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Humans; Infusion Pumps; Mice; Nanoparticles; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; rhoA GTP-Binding Protein; RNA, Small Interfering | 2006 |
Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Cholic Acids; Drug Carriers; Mice; Mice, Inbred C3H; Molecular Weight; Nanoparticles; Neoplasm Transplantation; Neoplasms; Polymers | 2007 |
Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Crystallization; Delayed-Action Preparations; Diffusion; Doxorubicin; Drug Carriers; Fibroblasts; Humans; Hydrophobic and Hydrophilic Interactions; Materials Testing; Mice; Nanoparticles; Neoplasms; Particle Size | 2007 |
Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia.
Topics: Cell Line, Tumor; Chitosan; Coated Materials, Biocompatible; Drug Delivery Systems; Fever; Humans; Magnetics; Materials Testing; Nanoparticles; Neoplasms; Spectroscopy, Fourier Transform Infrared; Starch; X-Ray Diffraction | 2009 |
Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Drug Stability; Humans; Hydrolysis; Hydrophobic and Hydrophilic Interactions; Lactones; Mice; Mice, Nude; Nanoparticles; Neoplasms; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Docetaxel; Drug Carriers; Drug Stability; Humans; Hydrophobic and Hydrophilic Interactions; Male; Mice; Mice, Nude; Nanoparticles; Neoplasms; Particle Size; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique.
Topics: Carbohydrate Sequence; Chitin; Chitosan; Contrast Media; Dealkylation; Emulsions; Gadolinium; Gadolinium DTPA; Gamma Rays; Microspheres; Molecular Sequence Data; Neoplasms; Neutron Capture Therapy; Particle Size; Radioisotopes | 1999 |
Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization.
Topics: Animals; Chemistry, Pharmaceutical; Chitin; Chitosan; Contrast Media; Emulsions; Gadolinium DTPA; Injections; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microspheres; Neoplasms; Neutron Capture Therapy; Particle Size; Solutions | 1999 |
In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer.
Topics: Animals; Biocompatible Materials; Chitin; Chitosan; Gadolinium; Gadolinium DTPA; L Cells; Melanoma, Experimental; Mice; Nanotechnology; Neoplasms; Neutron Capture Therapy; Tumor Cells, Cultured | 2002 |